M&AAcquisition · Announced
Lilly acquires CrossBridge Bio
Lilly also has plans to buy Texas-based startup CrossBridge Bio, which is creating ADCs.
Biotech
The Houston edition · 2026
Houston · Photo: Wikimedia Commons (CC BY-SA 4.0)Life sciencescompanies in Houston
Oncology, life-science-tools, genomics, immunotherapy, cardiovascular and more: the companies building life sciences in Houston, Texas, with their founders, funding, team size and business models.
244 company profiles75 with recorded fundingNovember 2026 edition
Recent life sciences business events in Houston
Funding, M&A, contract wins and launches involving 317 life sciences companies in Houston, last 24 months: 16 funding rounds · 9 M&A deals · 1 Launch · 1 Contract. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: May 2026.
FundingPrivate placement
CNS Pharmaceuticals
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) has announced a private placement expected to generate approximately $22.5 million in gross proceeds, according to a press release.
Biotechnology
M&AAcquisition · Pending
Allianz acquires Amprion
Later in March, AllianzGI signed an agreement to acquire an indirect stake in Amprion, Germany's second-largest electricity transmission system operator.
Electricity Transmission / Energy Infrastructure
M&AAcquisition · Announced
Eli Lilly and Company acquires CrossBridge Bio
Lilly is acquiring CrossBridge Bio (~$300M reported) to bolster oncology capabilities — diversifies growth beyond obesity/diabetes.
Biotechnology
LaunchCEO Corner
Moleculin biotech
Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced the launch of its CEO Corner, a new platform featuring Walter Klemp, Chief Executive Officer.
FundingPrivate investment round
Coya therapeutics
Coya Therapeutics has raised about $11.1 million in a private investment round to support commercial-readiness efforts for COYA 302, its experimental immune-modulating therapy being…
M&AMerger · Completed
Salarius pharmaceuticals acquires Decoy therapeutics
Salarius Pharmaceuticals, Inc. (NasdaqCM:SLRX) completed the acquisition of Decoy Therapeutics Inc. on November 12, 2025.
Pharmaceutical
M&AAcquisition · Announced
Apollo global management acquires Amprion
This operation provides for Apollo to acquire a 25.1 % stake in Amprion from RWE for EUR 3.2 billion.
Electricity transmission system operator
FundingSeries A
Spark biomedical
Dallas-based Spark Biomedical, an innovator in drug-free wearable neurostimulation technology, has closed its $15M Series A fundraising round.
M&AMerger · Completed
Tvardi therapeutics acquires Cara therapeutics
Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to…
Clinical-stage biopharmaceutical
M&AMerger · Completed
Cara therapeutics acquires Tvardi therapeutics
On April 15, 2025, Cara Therapeutics completed its merger with Tvardi Therapeutics, resulting in the formation of a Nasdaq-listed company named Tvardi Therapeutics, Inc.
FundingEquity financing commitment
Encysive pharmaceuticals
Encysive Pharmaceuticals Inc. (ENCY) Equity financing commitment N/A N/A Azimuth Opportunity Ltd. committed to buy up to $75M of registered Encysive stock over 18 months, at a discount…
Investors Azimuth
FundingSeries A
Cellenkos
Cellenkos Inc., of Houston, closed its $15 million series A financing led by BVCF Management Ltd.
Investors BVCF Management Ltd.
Biotech
FundingInitial Public Offering
Bellicum pharmaceuticals
Bellicum Pharmaceuticals Inc., of Houston, set the terms for its initial public offering, planning to raise $10 million by selling 6.3 million shares at a price range of $15 to $17.
FundingInitial investment
Signase
Signase closed an initial investment of an undisclosed amount; investors included A.M. Pappas & Associates, BioCapital Investment LP, as well as members of the management team
Investors A.M. Pappas & Associates, Biocapital, Members of the management team
FundingSeries C
Bacterial barcodes
Bacterial BarCodes raised $6M in additional funding in its Series C financing, led by Techxas Ventures; other investors were Koch Ventures and Pacific Rim Ventures, as well as the Baylor…
FundingSeries B
Esperance pharmaceuticals
Esperance Pharmaceuticals Inc., of Baton Rouge, La., closed a $7.5 million Series B financing to support development of its lead cancer candidate, EP-100.
Pharmaceutical
FundingMinority investment
eCardio Diagnostics
eCardio Diagnostics (The Woodlands, Texas) said it has received a significant minority investment from Sequoia Capital.
Investors Sequoia capital
Cardiac monitoring
FundingSeries A
Glycos biotechnologies
Glycos Biotechnologies Inc., of Houston, has closed a $5 million Series A round led by venture capital firms Draper Fisher Jurvetson and DFJ Mercury.
M&AMerger · Announced
Allovir acquires Kalaris Therapeutics Inc.
Allovir Inc., which has struggled since late last December, will merge with privately held Kalaris Therapeutics Inc. to develop therapies for treating neovascular and exudative retinal…
M&AMerger · Completed
Micromed technology acquires Salmon Express (wholly owned subsidiary)
MicroMed Technology (Houston), a developer of miniaturized implantable ventricular assist technology, reported completing its previously announced merger with a wholly owned subsidiary…
FundingFinancing
Alleviant medical
Alleviant Medical, an Austin, TX-based developer of innovative heart failure treatments, has announced a $90 million financing round led by Gilde Healthcare. The funding will support the…
Heart failure treatment
ContractSupply
Hitachi energy · client: Amprion
Hitachi Energy has signed contracts totaling over $2 billion with German transmission system operator (TSO) Amprion to deliver four converter stations for two high-voltage direct current…
Energy Infrastructure
FundingPrivate financing
Tvardi therapeutics
Tvardi has recently completed an approximately $28 million private financing, which, together with Tvardi’s existing cash and Cara’s anticipated cash balance, is expected to fund the…
Biopharmaceutical
FundingDebt financing
Invectys
Invectys has filed a notice of an exempt offering of securities to raise $4 Million in New Debt Financing.
Clinical-stage, cancer, immunotherapy
FundingSeries A
March biosciences
London, United Kingdom, 23 October 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm unlocking the treatments of the future by investing in advanced…
Biotechnology, Cell & Gene Therapy
FundingPrivate placement
Coya therapeutics
Coya Therapeutics Inc. (NASDAQ: COYA) witnessed a 9% increase in its share value after securing $10 million through a private placement.
Investors Na
Biotechnology
Life sciences companies in Houston, by funding and team
Few life sciences companies in Houston, Texas publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 244 active companies.
Developing drugs and delivery system along with theranostic imaging primarily for CNS disorders
Life sciences platforms and toolsUS$300.00mSeries D · Oct 2021
3LinkedIn · Jul 2026
E-commerce - product / Physical commerce
12 yr2014
—No postings tracked
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$300.00m · Series D · Oct 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series D
- Focus
- Drugs, Pain, Research services, Diversified
Founders · 1
Elias JacksonCo-Founder & President
- Highest education
- Philosophy · University Of Texas Medical Branch
Team & hiring signals
LinkedIn headcount311-50
LinkedIn followers177
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a robotic system for endoluminal and single-incision surgery
Professional service robotsUS$232.48mSeries D · May 2025
80+0% 12 mo to Dec 2021LinkedIn · Jul 2026
Physical commerce
9 yr2017
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 21 (previous snapshot 40)
- Recorded funding
- US$232.48m · Series D · May 2025
- Founded
- 2017 · about 9 years old
- Stage
- Series D
- Focus
- Healthcare, Surgery, Robotic surgery
Funding over time
US$232.48m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Kurt AzarbarzinCEO
Investors · 5
Team & hiring signals
LinkedIn headcount8051-200
LinkedIn followers14,236
Earlier recorded team212021, a different source
Recent company signals
- Partnership Partnership with NVIDIA
Patents
Patent filings135
Focus: Robotic surgical system control, instrumentation, and accessories for minimally invasive procedures.
CPC A61B34/30, A61B34/74, A61B34/37Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of devices to lift the burden of heart failure
Cardiac and vascular disordersUS$179.87mSeries C · Dec 2024
58+19% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 37 (previous snapshot 31)
- Recorded funding
- US$179.87m · Series C · Dec 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutic devices, Congestive heart failure
Funding over time
US$179.87m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jacob Kriegel MdCo-Founder & CMO
- Highest education
- Bachelor's in biology · Columbia University In The City Of New York
Investors · 10
Gilde HealthcareFund
Omega FundsFund
S3 VenturesFund
ShangBay CapitalFund
Vensana CapitalFund
Team & hiring signals
LinkedIn headcount5811-50
LinkedIn followers4,606
Technology
React
Next.js
Node.js
Cloudflare
Vercel
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of T-cell therapies to treat infectious diseases
Life sciences platforms and toolsUS$151.25mSeries B · May 2019
13+0% 12 mo to Dec 2022LinkedIn · Oct 2026
Fee-for-service
13 yr2013
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 97 (previous snapshot 135)
- Recorded funding
- US$151.25m · Series B · May 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Drugs, Viral, Diversified, Research services
Funding over time
US$151.25m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David HallalCo-Founder
- Highest education
- Bachelor's · University Of New Hampshire
Investors · 9
EcoR1Fund
ElevateBioFund
F2 VenturesFund
GileadFund
InvusFund
Redmile GroupFund
SVB SecuritiesFund
Team & hiring signals
LinkedIn headcount1351-200
LinkedIn followers9,265
Earlier recorded team972022, a different source
Patents
Patent filings8
Focus: Ex vivo expansion and manufacturing of multivirus-specific T‑cell therapies for transplant immunotherapy
CPC C12M23/24, A61P31/20, A61K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of T cell therapies for the treatment of cancer and chronic infectious diseases
ImmunotherapyUS$137.53mSeries C · Sep 2014
18-33% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
22 yr2004
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 108
- Recorded funding
- US$137.53m · Series C · Sep 2014
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$137.53m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom FarrellCEO
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Investors · 8
- Redmile GroupFund
Solasta VenturesFund
VenBioFund
RemeditexFund
Team & hiring signals
LinkedIn headcount1811-50
LinkedIn followers9,740
Earlier recorded team1082022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a novel cancer therapy targeting Treg cells
OncologyUS$121.40mSeries C · Jul 2025
15LinkedIn · Jul 2026
Fee-for-service
23 yr2003
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- US$121.40m · Series C · Jul 2025
- Founded
- 2003 · about 23 years old
- Stage
- Series C
- Focus
- Diversified, Drugs
Funding over time
US$121.40m across 2 disclosed equity rounds
Darker bars = larger roundsTeam & hiring signals
LinkedIn headcount1551-200
LinkedIn followers744
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developing percutaneous mechanical circulatory support for heart failure and cardiorenal syndrome
Cardiac and vascular disordersUS$114.35mSeries E · Feb 2024
27LinkedIn · Jul 2026
Physical commerce
21 yr2005
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 28
- Recorded funding
- US$114.35m · Series E · Feb 2024
- Founded
- 2005 · about 21 years old
- Stage
- Series E
- Focus
- Medical devices, Therapeutic devices, Congestive heart failure
Funding over time
US$114.35m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Eric FainPresident and CEO
- Highest education
- Doctor of medicine in medicine · Stanford University School Of Medicine
Investors · 4
Texas.govFund
Bluebird VenturesFund
Team & hiring signals
LinkedIn headcount2711-50
LinkedIn followers8,876
Patents
Patent filings100
Focus: Percutaneous intravascular blood pumps for mechanical circulatory support and perfusion.
CPC A61M60/139, A61M60/865, F04D3/02Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of immunotherapeutics for the treatment of cancer
OncologyUS$110.76mSeries C · Apr 2025
15LinkedIn · Jul 2026
Subscription
7 yr2019
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$110.76m · Series C · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series C
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$110.76m across 4 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Steve GorlinCEO
Team & hiring signals
LinkedIn headcount1551-200
LinkedIn followers744
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of small molecule based therapeutics for cancer treatment
OncologyUS$83.00mSeries B · Jun 2021
20LinkedIn · Jul 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months
Acquirer · 1 deal
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 15
- Recorded funding
- US$83.00m · Series B · Jun 2021
- Founded
- 2017 · about 9 years old
- Stage
- Series B
- Focus
- Drugs, Autoimmune diseases, Diversified
Funding over time
US$83.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
David J TweardyCo-Founder & President
Ron DePinhoCo-Founder
- Highest education
- Doctor of Medicine · Einstein Med
Investors · 3
Palkon Capital ManagementFund
Team & hiring signals
LinkedIn headcount2011-50
LinkedIn followers2,945
Technology
AWS
PHP
MySQL
WordPress
jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of drugs for treating leukemia disease
OncologyUS$65.80mSeries A · Jan 2022
8LinkedIn · Jul 2026
Physical commerce
8 yr2018
0none in 3 months · last posted Feb 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 2 (previous snapshot 2)
- Recorded funding
- US$65.80m · Series A · Jan 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, Blood cancer
Funding over time
US$65.80m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Leo LinbeckFounder
- Highest education
- MBA · Stanford Graduate School of Business
Investors · 5
- Boxer CapitalFund
Nextech InvestFund
OrbimedFund- Arjun GoyalAngel
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers804
Open roles1of 1 tracked · last posted Feb 2026
- Hiring: Manager/Sr. Manager, Clinical Operations – Oncology · Houston, TX
Recent company signals
- Milestone received FDA Fast Track designation for lead program, a monoclonal antibody for the treatment of relapsed or refractory acute lymphoblastic
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of cell-separation technology for regenerative medicine
Life sciences platforms and toolsUS$51.40mSeries D · Feb 2024
15LinkedIn · Jul 2026
Fee-for-service
21 yr2005
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 30
- Recorded funding
- US$51.40m · Series D · Feb 2024
- Founded
- 2005 · about 21 years old
- Stage
- Series D
- Focus
- Research services, Diversified, Drugs
Funding over time
US$51.40m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Michael ColemanEx-President & CEO
Investors · 1
Sanford HealthFund
Team & hiring signals
LinkedIn headcount1511-50
LinkedIn followers4,118
Recent company signals
- Milestone successful certification under the EU Medical Device Regulation (EU) 2017/745 CE Certification under EU Medical Device Regulation (MDR) 2017
Patents
Patent filings80
Focus: Patents concentrated in chemistry & materials
CPC C12N5/0653, C12N5/0667, A61K35/28Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of genomic services for forensic labs
GenomicsUS$48.70mSeries B · Feb 2024
90+16% 12 mo to Dec 2021LinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months · last posted Jan 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 22 (previous snapshot 41)
- Recorded funding
- US$48.70m · Series B · Feb 2024
- Founded
- 2018 · about 8 years old
- Stage
- Series B
- Focus
- Applied genomics, Other applications, Legal and forensic genomics
Funding over time
US$48.70m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David MittelmanCo-Founder & CEO
- Highest education
- Doctorates in molecular biophysics · Baylor College Of Medicine
Investors · 1
GigafundFund
Team & hiring signals
LinkedIn headcount9051-200
LinkedIn followers10,482
Earlier recorded team222021, a different source
Open roles0of 1 tracked · last posted Jan 2025
Patents
Patent filings8
Focus: Secure storage and privacy-preserving processing of genomic data
CPC G06N3/123, G16B40/10Technology
- AWS
- Cloudflare
Zendesk
Shopify- CloudFront
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of immunotherapeutic cancer treatments targeting HLA‑G antigen
ImmunotherapyUS$44.49mSeries A · Sep 2024
12LinkedIn · Jul 2026
Physical commerce
16 yr2010
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 25
- Recorded funding
- US$44.49m · Series A · Sep 2024
- Founded
- 2010 · about 16 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Applied genomics, Clinical genomics
Funding over time
US$44.49m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Simon Wain-HobsonCo-Founder & CSO
- Highest education
- Doctorates in biochemistry · University Of Oxford
Pierre DemoyenCo-Founder & Co-CEO
- Highest education
- Institut Pasteur
Investors · 1
BpifranceFund
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers2,866
Patents
Patent filings4
Focus: Engineered CAR‑T cell immunotherapy targeting HLA‑G antigen
CPC C07K14/7051Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutic solutions for treating tumors
ImmunotherapyUS$44.43mSeries C · Mar 2024
16+8% vs previous recordLinkedIn · Jul 2026
Fee-for-service
7 yr2019
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14 (previous snapshot 13)
- Recorded funding
- US$44.43m · Series C · Mar 2024
- Founded
- 2019 · about 7 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Founders · 1
Michael CurranFounder
- Highest education
- Biology · University of Virginia
Team & hiring signals
LinkedIn headcount1611-50
LinkedIn followers1,518
Recent company signals
- Partnership Partnership with BostonGene
- Award SITC 2025 Award Recipients
Patents
Patent filings18
Focus: Targeted hypoxia‑activated prodrugs and STING agonist combos for cancer immunotherapy
CPC A61K31/396, A61K31/675, A61K31/7084Technology
- PHP
- MySQL
- Cloudflare
- WordPress
Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Oncolytic virus platform for treating malignant glioma.
ImmunotherapyUS$42.96mSeries C · Sep 2018
4+18% vs previous recordLinkedIn · Jul 2026
Subscription
21 yr2005
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 11)
- Recorded funding
- US$42.96m · Series C · Sep 2018
- Founded
- 2005 · about 21 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$42.96m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Frank TufaroCEO
- Highest education
- Bachelor's in biology · Mcgill University
Investors · 3
Mercury FundFund
- MorningsideFund
Team & hiring signals
LinkedIn headcount411-50
LinkedIn followers2,066
Patents
Patent filings81
Focus: Oncolytic adenovirus gene therapies targeting pediatric brain tumors and immune activation
CPC A61K35/761, C12N7/00, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of targeted radiopharmaceuticals for cancer diagnosis and treatment
Imaging diagnosticsUS$40.00mSeries A · Oct 2022
44-21% vs previous recordLinkedIn · Jul 2026
Fee-for-service
20 yr2006
0none in 3 months · last posted Mar 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 26 (previous snapshot 33)
- Recorded funding
- US$40.00m · Series A · Oct 2022
- Founded
- 2006 · about 20 years old
- Stage
- Series A
- Focus
- Drugs, Pan cancer, Accessories, Radioisotopes
Founders · 2
Izabela TworowskaCo-Founder & CSO
- Highest education
- Rice University
Azar DelpassandCo-Founder & President
- Highest education
- Bachelor's of science in nursing in nursing · University Of Tehran
Investors · 1
PortlandFund
Team & hiring signals
LinkedIn headcount4411-50
LinkedIn followers6,206
Open roles1of 1 tracked · last posted Mar 2026
Recent company signals
- Milestone abbreviated New Drug Application (ANDA) FDA approval for generic Ga-68 PSMA-11
Patents
Patent filings65
Focus: Automated production of lead‑212 radionuclide for targeted alpha‑particle cancer therapy
CPC A61K51/0497, A61P35/00, C07H17/07Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapies for cancer and immune diseases
OncologyUS$38.10mSeries A · May 2021
8LinkedIn · Jul 2026
Commission on transaction / Fee-for-service
6 yr2020
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, Fee-for-service
- Team size
- Not available
- Recorded funding
- US$38.10m · Series A · May 2021
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Founders · 1
Peter FeinbergCo-Founder
- Highest education
- Finance · Whittier College
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers1,160
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provides services to store adult stem cells for medical treatments
Life sciences platforms and toolsUS$34.06mSeries B · Jul 2012
33+3% 12 mo to Dec 2022LinkedIn · Jul 2026
Commission on transaction / Fee-for-service
15 yr2011
0none in 3 months
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, Fee-for-service
- Team size
- 34 (previous snapshot 39)
- Recorded funding
- US$34.06m · Series B · Jul 2012
- Founded
- 2011 · about 15 years old
- Stage
- Series B
- Focus
- Research services, Biorepository
Founders · 1
Stanley JonesCo-Founder & CMO
- Highest education
- Doctor of medicine in medicine · Ut Southwestern Medical Center
Team & hiring signals
LinkedIn headcount3311-50
LinkedIn followers3,952
Earlier recorded team342022, a different source
Technology
- PHP
- MySQL
Nginx- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of CAR-T cell therapies for malignancies
OncologyUS$33.20mSeries A · Oct 2024
24LinkedIn · Jul 2026
Fee-for-service
4 yr2022
0none in 3 months · last posted Dec 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- US$33.20m · Series A · Oct 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$33.20m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Max MamonkinCo-Founder and CSO
Sarah HeinCo-Founder & CEO
- Highest education
- Doctor of Philosophy, Biology · Baylor College of Medicine
Malcolm BrennerCo-Founder
Investors · 11
4Bio CapitalFund
AlexandriaFund
KdT VenturesFund
Mansueto OfficeFund
Modi VenturesFund
Team & hiring signals
LinkedIn headcount242-10
LinkedIn followers4,262
Open roles1of 1 tracked · last posted Dec 2025
- Hiring: Clinical Sample & Logistics Specialist · Houston, Texas
Recent company signals
- Leadership Hired a Chief Business Officer
- Milestone regulatory update regulatory update
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of immunotherapeutics for cancer treatment
NeurologyUS$31.40mSeed · Jun 2025
24LinkedIn · Jul 2026
Fee-for-service
4 yr2022
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- US$31.40m · Seed · Jun 2025
- Founded
- 2022 · about 4 years old
- Stage
- Seed
- Focus
- Drugs, Diversified
Funding over time
US$31.40m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Mike WicksCEO
- Highest education
- Bachelor's of Engineering, Mechanical Engineering · Auburn University
Investors · 5
- RestemFund
- Buttonwood Titan QC FundFund
- Mike WicksAngel
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers2,250
Recent company signals
- Partnership Partnership with Natera
- Milestone FDA Fast Track designation for DOC1021 (dubodencel) FDA Fast Track designation for DOC1021 (dubodencel) in unresectable or metastatic cutane
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment
Healthcare itUS$31.23mSeries A · Apr 2025
27+50% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
8 yr2018
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 18 (previous snapshot 12)
- Recorded funding
- US$31.23m · Series A · Apr 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Neurological disorders, Therapy, Deaddiction, Opioid management
Funding over time
US$31.23m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Daniel PowellCEO
- Highest education
- Bachelor's in marketing · Texas A&M University
Investors · 2
- Pathway to CuresFund
- Wave VenturesFund
Team & hiring signals
LinkedIn headcount2711-50
LinkedIn followers7,130
Earlier recorded team182022, a different source
Recent company signals
- Award HardTech Awards
- Leadership Hired a Chief Executive Officer
Patents
Patent filings61
Focus: Non‑invasive auricular neurostimulation devices for women's health therapies
CPC A61N1/36036, A61N1/0456, A61N1/36014Mobile apps
- Sparrow Link ParticipantMedical · 6 installs · updated 2026-02-11
Technology
- Cloudflare
Sentry
HubSpot
Webflow- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of endovascular robotics and steerable guidewires
NeurologyUS$30.00mSeries C · Mar 2026
37LinkedIn · Jul 2026
Subscription
9 yr2017
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 10
- Recorded funding
- US$30.00m · Series C · Mar 2026
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutic devices, Cerebrovascular disorder, Interventional neurology
Leadership · 1
Eduardo FonsecaCEO
- Highest education
- Master's of Business Administration · INSEAD
Investors · 2
- Frederic MollAngel
Team & hiring signals
LinkedIn headcount3751-200
LinkedIn followers2,253
Earlier recorded team102022, a different source
Recent company signals
- Milestone 2.8% of patients have access to mechanical thrombectomy first remote robotic intervention in a stroke patient
- Milestone first-in-human use of EVR endovascular robotic system to treat brain aneurysms
Patents
Patent filings128
Focus: Patents concentrated in health & consumer products
CPC A61M25/0158, A61M25/09041, A61M25/0113Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a device for the detection of internal bleeding during catheterization
Cardiac and vascular disordersUS$29.46mSeries B · Jul 2021
8LinkedIn · Jul 2026
Subscription
15 yr2011
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 22
- Recorded funding
- US$29.46m · Series B · Jul 2021
- Founded
- 2011 · about 15 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Vascular access and closure
Funding over time
US$29.46m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mehdi RazaviFounder and Chairman
- Highest education
- Doctor of medicine · Mayo Clinic School Of Health Sciences
Investors · 2
Baird CapitalFund- S3 VenturesFund
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers3,167
Patents
Patent filings43
Focus: Vascular access closure devices with real-time bleed detection via bioimpedance monitoring
CPC A61B5/02042, A61B17/0057, A61B5/4881Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for the treatment of cancer
OncologyUS$28.82mSeries B · Feb 2021
16-17% vs previous recordLinkedIn · Jul 2026
Physical commerce
16 yr2010
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 10 (previous snapshot 12)
- Recorded funding
- US$28.82m · Series B · Feb 2021
- Founded
- 2010 · about 16 years old
- Stage
- Series B
- Focus
- Drugs, Pan cancer
Funding over time
US$28.82m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Rahul ArasCEO & President
Investors · 7
GOOSEFund
Lumira VenturesFund
SanteFund
Sante VenturesFund
Team & hiring signals
LinkedIn headcount1611-50
LinkedIn followers2,781
Recent company signals
- Milestone Phase 1 clinical data presented at ASCO Annual Meeting
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of ventricular assist device (VAD)
Cardiac and vascular disordersUS$28.00mSeries B · Jul 2024
77-22% vs previous recordLinkedIn · Jul 2026
Physical commerce
18 yr2008
0none in 3 months · last posted Jun 2026
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 29 (previous snapshot 37)
- Recorded funding
- US$28.00m · Series B · Jul 2024
- Founded
- 2008 · about 18 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Congestive heart failure
Funding over time
US$28.00m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Daniel TimmsCEO
- Highest education
- Doctorates in biomedical engineering · Qut Faculty Of Education
Investors · 2
One VenturesFund
Team & hiring signals
LinkedIn headcount7711-50
LinkedIn followers15,570
Open roles5of 5 tracked · last posted Jun 2026
- Hiring: Senior Manager, Quality Engineering · Huntington Beach, California
- Hiring: Lead Electrical Manufacturing Engineer · Huntington Beach, California
- Hiring: Quality Inspector · Hawington Beach, California
Patents
Patent filings45
Focus: Design and control of ventricular assist blood pumps and heart pump drive systems
CPC A61M60/178, A61M60/232, A61M60/82Technology
- PHP
- MySQL
- Nginx
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of axial flow pump for congestive heart failure
Cardiac and vascular disordersUS$28.00mSeries A · Jan 2005
15-44% 12 mo to Dec 2012recorded Dec 2012
E-commerce - product / Physical commerce
31 yr1995
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 15
- Recorded funding
- US$28.00m · Series A · Jan 2005
- Founded
- 1995 · about 31 years old
- Stage
- Series A
- Focus
- Medical devices, Therapeutic devices, Congestive heart failure
Funding over time
US$28.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Dallas AndersonCo-Founder
- Highest education
- Bachelor's in business administration · The University Of Georgia
Investors · 5
Charterhouse Strategic PartnersFund
Patents
Patent filings45
Focus: Implantable blood pump and ventricular assist device flow measurement and calibration systems
CPC A61M60/422, A61M1/3663, A61M60/237Technology
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of regenerative science to treat various health conditions
DermatologyUS$27.00mSeries A · Jan 2026
14LinkedIn · Jul 2026
E-commerce - product / Physical commerce
4 yr2022
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$27.00m · Series A · Jan 2026
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Exosome based
Funding over time
US$27.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Steven GrecoFounder & COO
- Highest education
- BA · Cornell University
Team & hiring signals
LinkedIn headcount1411-50
LinkedIn followers1,860
Recent company signals
- Leadership Hired a Chief Medical Officer
Technology
- Cloudflare
- HubSpot
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics against lung infections
PulmonologyUS$25.14mSeries B · Aug 2024
9+33% 12 mo to Dec 2021LinkedIn · Jul 2026
Physical commerce
19 yr2007
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 4 (previous snapshot 12)
- Recorded funding
- US$25.14m · Series B · Aug 2024
- Founded
- 2007 · about 19 years old
- Stage
- Series B
- Focus
- Drugs, Lung infections
Funding over time
US$25.14m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Brenton ScottPresident & Co-Founder
Investors · 2
Team & hiring signals
LinkedIn headcount92-10
LinkedIn followers622
Earlier recorded team42021, a different source
Patents
Patent filings21
Focus: Immunomodulatory therapeutics targeting adaptive immunity for asthma and viral infection treatment
CPC A61K39/35, A61K39/39Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of nanoparticle-based cancer treatment for solid tumors
NanotechnologyUS$24.52mSeries B · Mar 2023
5+12% 12 mo to Dec 2020LinkedIn · Jul 2026
Physical commerce
24 yr2002
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 9 (previous snapshot 2)
- Recorded funding
- US$24.52m · Series B · Mar 2023
- Founded
- 2002 · about 24 years old
- Stage
- Series B
- Focus
- Medical devices, Therapies, Radiation therapy, Nanoenabled products
Funding over time
US$24.52m across 11 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
David JordenInterim CEO & Bord of Directors
Investors · 1
Sirtex MedicalFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers292
Earlier recorded team92020, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of antibody inhibitors for camcer therapy
ImmunotherapyUS$24.42mSeries B · Feb 2014
5-64% 12 mo to Dec 2023recorded Dec 2023
Physical commerce
18 yr2008
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 5 (previous snapshot 40)
- Recorded funding
- US$24.42m · Series B · Feb 2014
- Founded
- 2008 · about 18 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$24.42m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 3
Gail McIntyreCEO
Ray TabibiazarCEO
- Highest education
- Doctor Of Medicine - Md · Harvard University
Ray TabibiazarCEO
- Highest education
- Doctor Of Medicine - Md · Harvard University
Patents
Patent filings39
Focus: AXL pathway inhibition via decoy receptors and peptides for anti‑metastatic cancer therapy
CPC C12N9/12, A61K38/177, A61K38/45Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of treatments for primary and metastatic cancers in the brain and central nervous system
OncologyUS$22.52mSeries B · May 2026
13+0% 12 mo to Dec 2021LinkedIn · Oct 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months · last posted May 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 5 (previous snapshot 7)
- Recorded funding
- US$22.52m · Series B · May 2026
- Founded
- 2017 · about 9 years old
- Stage
- Public
- Focus
- Drugs, Brain cancer
Leadership · 1
John ClimacoCEO
Team & hiring signals
LinkedIn headcount132-10
LinkedIn followers2,188
Earlier recorded team52021, a different source
Open roles1of 1 tracked · last posted May 2026
- Hiring: AD/Director, Business Development
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for cell therapy and exosome therapy
ImmunotherapyUS$20.44mSeries A · May 2022
18-40% vs previous recordLinkedIn · Oct 2026
E-commerce - product / Physical commerce
6 yr2020
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 6 (previous snapshot 10)
- Recorded funding
- US$20.44m · Series A · May 2022
- Founded
- 2020 · about 6 years old
- Stage
- Public
- Focus
- Drugs, Neurodegenerative, Diversified, Immuno oncology
Funding over time
US$20.44m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Howard BermanCo-Founder & CEO
- Highest education
- Bachelor's's degree, Biology/Biological Sciences, General · University of Michigan
Team & hiring signals
LinkedIn headcount182-10
LinkedIn followers5,805
Earlier recorded team62022, a different source
Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of topical, non-opioid analgesics to alleviate pain
NeurologyUS$18.83mSeries C · Jan 2018
2+0% 12 mo to Dec 2017LinkedIn · Jul 2026
E-commerce - product / Physical commerce
19 yr2007
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 5 (previous snapshot 2)
- Recorded funding
- US$18.83m · Series C · Jan 2018
- Founded
- 2007 · about 19 years old
- Stage
- Series C
- Focus
- Drugs, Pain, Anaesthesia
Funding over time
US$18.83m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Phillip PhanCo-Founder
Allen BurtonCo-Founder
- Highest education
- Doctor of medicine in medicine · Harvard Medical School
Danguole AltmanFounder
- Highest education
- Master's of business administration · Yale School Of Management
Investors · 2
Pamoja CapitalFund
Team & hiring signals
LinkedIn headcount22-10
LinkedIn followers253
Earlier recorded team52017, a different source
Patents
Patent filings54
Focus: Pain‑relief drug formulations using halogenated volatile compounds for analgesic therapy.
CPC A61K31/08, A61K8/69, A61K9/0014Technology
- PHP
- MySQL
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of minimally invasive bioelectronics for mental health disorders
NeurologyUS$18.75mSeries A · Jan 2024
32-36% vs previous recordLinkedIn · Jul 2026
Physical commerce / Subscription
4 yr2022
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 7 (previous snapshot 11)
- Recorded funding
- US$18.75m · Series A · Jan 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Medical devices, Therapeutic devices, Psychiatric, Neurological disorders
Founders · 1
Jacob RobinsonCo-Founder & CEO
- Highest education
- Applied Physics · Cornell University
Investors · 11
Capital FactoryFund
Empath VenturesFund- KdT VenturesFund
PsyMed VenturesFund
Satori CapitalFund
Team & hiring signals
LinkedIn headcount3211-50
LinkedIn followers14,312
Recent company signals
- Partnership Partnership with Wells Medicine
- Leadership Hired a Board of Directors
Patents
Patent filings8
Focus: Closed-loop neural interfaces using implantable magnetoelectric stimulation and wireless monitoring
CPC A61N1/36139, A61N1/3615, G16H20/40Technology
- Cloudflare
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Industrial biotechnology company focusing on development of specialty chemicals and food supplements
Nutraceuticals techUS$16.78mSeries A · Mar 2024
8+40% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
19 yr2007
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 7 (previous snapshot 9)
- Recorded funding
- US$16.78m · Series A · Mar 2024
- Founded
- 2007 · about 19 years old
- Stage
- Series A
- Focus
- Dietary supplements, Disease specific, Diversified
Funding over time
US$16.78m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Daniel MonticelloCo-Founder
Richard CilentoCo-Founder
- Highest education
- BS · University of Illinois
Investors · 3
DFJFund
EIV CapitalFund- Mercury FundFund
Team & hiring signals
LinkedIn headcount811-50
LinkedIn followers1,055
Earlier recorded team72022, a different source
Patents
Patent filings21
Focus: Lipid-based monoacylglycerol/fatty acid formulations for drug and cosmetic delivery
CPC A23D7/011, C11C1/045, A61K31/23Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of generative AI based RNAstate research platform to predict future omics states
Life sciences techUS$16.00mSeries A · Apr 2025
26LinkedIn · Jul 2026
Subscription
3 yr2023
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$16.00m · Series A · Apr 2025
- Founded
- 2023 · about 3 years old
- Stage
- Series A
- Focus
- Research & development, Medical ai data validation
Funding over time
US$16.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Ashwin GopinathCo-Founder & CTO
- Highest education
- PhD · Boston University
David ZhangCo-Founder & CEO
- Highest education
- University of Michigan
Investors · 10
- AccelFund
CatapultFund
GaingelsFund
Mana VenturesFund
- CaltechFund
- Dario AmodeiAngel
Team & hiring signals
LinkedIn headcount2651-200
LinkedIn followers13,533
Recent company signals
- Partnership Partnership with Earendil Labs
Patents
Patent filings7
Focus: AI‑enhanced nucleic‑acid analysis and microfluidic blood cell separation for biomarker quantification
CPC C12N15/1096, G06N20/00, G16H50/20Technology
- React
- Next.js
- Node.js
- Vercel
Tailwind CSS
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of cell-derived therapeutics solutions for the treatment of cardiac health, stroke & kidney transplantation
NephrologyUS$15.50mSeed · Sep 2025
10+20% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
6 yr2020
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 12 (previous snapshot 10)
- Recorded funding
- US$15.50m · Seed · Sep 2025
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Drugs, Acute kidney diseases, Diversified, Renal disorders
Funding over time
US$15.50m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Alexander SchuellerFounder & CEO
- Highest education
- PhD · RWTH Aachen University
Investors · 3
BeiersdorfFund
KizooFund
Taiho VenturesFund
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers5,742
Patents
Patent filings10
Focus: Optimizing manufacturing and potency of adoptive immune cell therapies
CPC C12N5/0636, A61K40/42Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of cancer therapies for targeting cancer-associated fibroblasts
OncologyUS$15.50mSeries A · Jun 2021
1LinkedIn · Jul 2026
Fee-for-service
7 yr2019
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 5
- Recorded funding
- US$15.50m · Series A · Jun 2021
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Founders · 3
Rosa HwangCo-Founder
Ronald DePinhoFounder
Emmanuelle SchulerFounder & CEO
Investors · 1
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers323
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of medicines for cancer, autoimmune, and infectious diseases
ImmunotherapyUS$14.50mSeries A · Mar 2021
4recorded
E-commerce - product / Physical commerce
7 yr2019
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 4 (previous snapshot 2)
- Recorded funding
- US$14.50m · Series A · Mar 2021
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Founders · 3
Richard JonesCo-Founder
Robert Z OrlowskiFounder
Ronald A DePinhoCo-Founder
Investors · 1
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of immunotherapies to treat cancer
ImmunotherapyUS$12.98mSeries A · Nov 2024
4+50% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
22 yr2004
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 9 (previous snapshot 6)
- Recorded funding
- US$12.98m · Series A · Nov 2024
- Founded
- 2004 · about 22 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Viral
Funding over time
US$12.98m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Bob CoatesCEO
- Highest education
- Bachelor's in economics · University Of Virginia
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers837
Recent company signals
- Milestone first NSCLC patient in MEM-288 + docetaxel Phase 1 combination cohort at Moffitt Cancer Center first NSCLC patient dosed
Patents
Patent filings72
Focus: Oncolytic viral platforms and immune‑modulating vaccine adjuvants for cancer and infectious disease
CPC A61K35/761, A61P35/00, A61K35/28Technology
- PHP
- MySQL
- WordPress
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Revolutionizing neurodegenerative disease diagnosis with advanced α-synuclein detection technology
NeurologyUS$11.76mSeries B · Oct 2024
37LinkedIn · Jul 2026
Subscription
20 yr2006
0none in 3 months
Social impactSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 34
- Recorded funding
- US$11.76m · Series B · Oct 2024
- Founded
- 2006 · about 20 years old
- Stage
- Series B
- Focus
- In-vitro diagnostics, Neurodegenerative
Funding over time
US$11.76m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Russ LebovitzCEO
- Highest education
- Doctor of medicine in molecular biology · Washington University School Of Medicine In St. Louis
Investors · 1
LillyFund
Team & hiring signals
LinkedIn headcount3711-50
LinkedIn followers3,119
Earlier recorded team342022, a different source
Patents
Patent filings95
Focus: Protein misfolding detection assays for neurodegenerative disease biomarkers
CPC G01N33/6896, C07K14/765, C07K14/47Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for cancer
OncologyUS$11.60mSeed · Mar 2023
1-17% vs previous recordLinkedIn · Jul 2026
Fee-for-service
7 yr2019
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 5 (previous snapshot 6)
- Recorded funding
- US$11.60m · Seed · Mar 2023
- Founded
- 2019 · about 7 years old
- Stage
- Seed
- Focus
- Drugs, Diversified
Leadership · 1
Frank PeraboCEO
Investors · 3
Khosla VenturesFund
- MarrittFund
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers464
Earlier recorded team52021, a different source
Patents
Patent filings8
Focus: Wireless multiple-access protocols, time synchronization, and spectrum allocation for CDMA systems
CPC H04W74/02, H04W74/004, H04W84/08Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Biotech targeting cellular metabolism for novel anti-cancer and anti-fibrosis therapies
ImmunotherapyUS$11.04mSeries B · Jan 2026
6LinkedIn · Jul 2026
Subscription
11 yr2015
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 9
- Recorded funding
- US$11.04m · Series B · Jan 2026
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$11.04m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Dean WelschCEO
- Highest education
- BS, ACS Approved, Chemistry · Hope College
Investors · 4
InterVestFund
Mirae Asset VentureFund
NHN InvestmentFund
Team & hiring signals
LinkedIn headcount62-10
LinkedIn followers435
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developing advanced imaging agents for early diagnosis of neurodegenerative diseases
Imaging diagnosticsUS$11.00mSeries A · Aug 2017
5-43% vs previous recordLinkedIn · Jul 2026
Subscription
15 yr2011
—No postings tracked
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 4 (previous snapshot 7)
- Recorded funding
- US$11.00m · Series A · Aug 2017
- Founded
- 2011 · about 15 years old
- Stage
- Series A
- Focus
- In-vitro diagnostics, Neurodegenerative, Alzheimer disease, Accessories
Leadership · 1
Robin MansukhaniPresident & CEO
- Highest education
- BS · Case Western Reserve University
Investors · 2
- Peter WerthAngel
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers286
Technology
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Manufacturer of algae-based nutritional products
Aquaculture techUS$10.00mSeries A · Jan 2021
21+9% vs previous recordLinkedIn · Jul 2026
E-commerce - product
9 yr2017
0none in 3 months
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product
- Team size
- 36 (previous snapshot 33)
- Recorded funding
- US$10.00m · Series A · Jan 2021
- Founded
- 2017 · about 9 years old
- Stage
- Series A
- Focus
- Dietary supplements, Algae based, Omega-3 supplements, Aquatic plants
Investors · 3
- AranciaFund
MinravFund
PeakBridgeFund
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers3,366
Patents
Patent filings37
Focus: Driver behavior monitoring and wireless device detection for vehicle telematics systems
CPC G07C5/085, H04K3/415, G07C5/0808Technology
Vue.js- Cloudflare
- Sentry
- Shopify
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Small molecule drugs for leukemia and other cancers
OncologyUS$9.69mSeries A · Jun 2013
22-5% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
20 yr2006
0none in 3 months · last posted Apr 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 19 (previous snapshot 21)
- Recorded funding
- US$9.69m · Series A · Jun 2013
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Funding over time
US$9.69m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Wally KlempFounder & CEO
Team & hiring signals
LinkedIn headcount222-10
LinkedIn followers5,049
Earlier recorded team192022, a different source
Open roles1of 1 tracked · last posted Apr 2026
Recent company signals
- Milestone 50% and 57% in Annamycin dose arms of Phase 2/3 MIRACLE trial, compared with 29% for control arm Composite complete remission (CRc)
Patents
Patent filings37
Focus: Liposomal formulation and lyophilized delivery of the anticancer agent annamycin.
CPC A61K31/704, A61K9/0019, A61K31/70Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of regenrative medicine for post surgical scarring
Regenerative medicineUS$8.35mSeries A · Jan 2025
15LinkedIn · Jul 2026
E-commerce - product / Physical commerce
6 yr2020
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 7
- Recorded funding
- US$8.35m · Series A · Jan 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Diversified, Drugs, Surgical access and closure
Funding over time
US$8.35m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Alex SmithCo-Founder
Stephen RamonCo-Founder
Tim KeaneCo-Founder
- Highest education
- Doctorates in biomedical engineering · University Of Pittsburgh
Investors · 1
Y CombinatorFund
Team & hiring signals
LinkedIn headcount152-10
LinkedIn followers2,120
Recent company signals
- Milestone 100 patients treated
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of immunotherapeutics for treating cancer
OncologyUS$8.12mSeries A · Jan 2023
7LinkedIn · Jul 2026
E-commerce - product / Physical commerce
8 yr2018
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 6
- Recorded funding
- US$8.12m · Series A · Jan 2023
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Funding over time
US$8.12m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Sunil SharmaCo-Founder
Jon NorthrupCo-Founder & CEO
Investors · 1
Team & hiring signals
LinkedIn headcount7
LinkedIn followers719
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a device for gall stone surgical removal procedure
GastroenterologyUS$7.20mSeries A · Apr 2022
3+0% vs previous recordLinkedIn · Jul 2026
Fee-for-service
8 yr2018
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 6 (previous snapshot 6)
- Recorded funding
- US$7.20m · Series A · Apr 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Medical devices, Therapeutic devices, Liver and gall bladder
Funding over time
US$7.20m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David WatersCo-Founder & COO
- Highest education
- Doctor of medicine in medicine · The University Of Texas Medical School At Houston
Investors · 4
MedTex VenturesFund- S3 VenturesFund
TMC InnovationFund
Team & hiring signals
LinkedIn headcount32-10
LinkedIn followers328
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developing minimally invasive, non-blood contacting cardiac assist device for heart failure
Surgical instrumentsUS$6.10mSeries A · Oct 2017
20+25% 12 mo to Dec 2022LinkedIn · Jul 2026
Physical commerce
22 yr2004
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 10 (previous snapshot 15)
- Recorded funding
- US$6.10m · Series A · Oct 2017
- Founded
- 2004 · about 22 years old
- Stage
- Series A
- Focus
- Healthcare, Surgery, Robotic surgery
Founders · 1
John CriscioneFounder & CTO
- Highest education
- PhD · Johns Hopkins University
Investors · 1
- Wellcome TrustFund
Team & hiring signals
LinkedIn headcount202-10
LinkedIn followers1,404
Earlier recorded team102022, a different source
Patents
Patent filings64
Focus: Optimizing loading and minimally invasive implantation of cardiac assist and compression devices
CPC A61F2/2481, A61M60/191, A61M60/497Technology
Google Cloud- React
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
50 of 244 companies shown here · the full list is on Radar
Fliar Radar
Explore all 244 life sciences companies in Houston on Radar
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in Houston on Radar- Every company, not just 50All 244 life sciences companies in Houston, filterable by stage, funding, team size, revenue model and age.
- Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
- Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
- Save and exportBuild lists, compare companies side by side and export them from your Radar account.
Explore life sciences companies in Houston by what you are looking for
Browse top life sciences companies in Houston across oncology, genomics, and medical technology. Find life sciences businesses in Houston by their research, therapies, and clinical tools.
9 ways to explore life sciences in Houston
Oncology & cancer therapy companiesLife science platforms & research toolsGenomics & genetic testing companiesImmunotherapy & cell therapy companiesCardiac & vascular medical device companiesNeurology & neurotechnology companies
Oncology & cancer therapy companies
Companies developing cancer therapies, oncology medicines, and related treatments.
- BellicumSee in list
Developer of T cell therapies for the treatment of cancer and chronic infectious diseases
Immunotherapy - CoRegenSee in list
Developer of a novel cancer therapy targeting Treg cells
Oncology - TvardiSee in list
Developer of small molecule based therapeutics for cancer treatment
Oncology - AllterumSee in list
Developer of drugs for treating leukemia disease
Oncology - InvectysSee in list
Developer of immunotherapeutic cancer treatments targeting HLA‑G antigen
Immunotherapy
78 companies in HoustonAll 74 oncology companies in Houston →
Life science platforms & research tools
Companies providing life science platforms, laboratory tools, and research technology.
- Vyripharm BiopharmaceuticalsSee in list
Developing drugs and delivery system along with theranostic imaging primarily for CNS disorders
Life sciences platforms and tools - AlloVirSee in list
Developer of T-cell therapies to treat infectious diseases
Life sciences platforms and tools - IngeneronSee in list
Developer of cell-separation technology for regenerative medicine
Life sciences platforms and tools - Celltex TherapeuticsSee in list
Provides services to store adult stem cells for medical treatments
Life sciences platforms and tools - BiostateSee in list
Developer of generative AI based RNAstate research platform to predict future omics states
Life sciences tech
64 companies in HoustonAll 36 life sciences platforms and tools companies in Houston →
Genomics & genetic testing companies
Companies offering genomics, genetic testing, sequencing, and clinical genetics services.
- BellicumSee in list
Developer of T cell therapies for the treatment of cancer and chronic infectious diseases
Immunotherapy - OthramSee in list
Provider of genomic services for forensic labs
Genomics - InvectysSee in list
Developer of immunotherapeutic cancer treatments targeting HLA‑G antigen
Immunotherapy 
Luna GeneticsDeveloper of a non-invasive pre-natal diagnostic test
Women health
MolecularMatchProvider of clinical intelligence platform for precision oncology and immunotherapy
Genomics
34 companies in HoustonAll 34 genomics companies in Houston →
Immunotherapy & cell therapy companies
Companies developing immunotherapy, cell therapy, and immune-focused treatments.
- AlloVirSee in list
Developer of T-cell therapies to treat infectious diseases
Life sciences platforms and tools - CoRegenSee in list
Developer of immunotherapeutics for the treatment of cancer
Oncology - TvardiSee in list
Developer of small molecule based therapeutics for cancer treatment
Oncology - Sporos BioventuresSee in list
Developer of therapies for cancer and immune diseases
Oncology - March BiosciencesSee in list
Developer of CAR-T cell therapies for malignancies
Oncology
39 companies in HoustonAll 1,069 immunotherapy companies in United States →
Cardiac & vascular medical device companies
Companies developing devices and treatments for cardiac and vascular conditions.
- Alleviant MedicalSee in list
Developer of devices to lift the burden of heart failure
Cardiac and vascular disorders - ProcyrionSee in list
Developing percutaneous mechanical circulatory support for heart failure and cardiorenal syndrome
Cardiac and vascular disorders - XCathSee in list
Developer of endovascular robotics and steerable guidewires
Neurology - SaranasSee in list
Developer of a device for the detection of internal bleeding during catheterization
Cardiac and vascular disorders - BivacorSee in list
Developer of ventricular assist device (VAD)
Cardiac and vascular disorders
50 companies in HoustonAll 1,315 cardiac and vascular disorders companies in United States →
Neurology & neurotechnology companies
Companies building therapies, devices, and technology for neurological conditions.
- Vyripharm BiopharmaceuticalsSee in list
Developing drugs and delivery system along with theranostic imaging primarily for CNS disorders
Life sciences platforms and tools - CNS PharmaceuticalsSee in list
Developer of treatments for primary and metastatic cancers in the brain and central nervous system
Oncology - Coya TherapeuticsSee in list
Developer of therapeutics for cell therapy and exosome therapy
Immunotherapy - VapogenixSee in list
Developer of topical, non-opioid analgesics to alleviate pain
Neurology - Motif neurotechSee in list
Developer of minimally invasive bioelectronics for mental health disorders
Neurology
23 companies in HoustonAll 1,624 neurology companies in United States →
Life sciences startups in Houston
Recently founded life sciences companies in Houston.
- March BiosciencesSee in list
Developer of CAR-T cell therapies for malignancies
Oncology - DiakonosSee in list
Provider of immunotherapeutics for cancer treatment
Neurology - PranaXSee in list
Provider of regenerative science to treat various health conditions
Dermatology - Motif neurotechSee in list
Developer of minimally invasive bioelectronics for mental health disorders
Neurology - BiostateSee in list
Developer of generative AI based RNAstate research platform to predict future omics states
Life sciences tech
31 companies in Houston
Life sciences companies hiring in Houston
Life sciences businesses in Houston with hiring activity.
- AllterumSee in list
Developer of drugs for treating leukemia disease
Oncology - OthramSee in list
Provider of genomic services for forensic labs
Genomics - RadioMedixSee in list
Developer of targeted radiopharmaceuticals for cancer diagnosis and treatment
Imaging diagnostics - March BiosciencesSee in list
Developer of CAR-T cell therapies for malignancies
Oncology - BivacorSee in list
Developer of ventricular assist device (VAD)
Cardiac and vascular disorders
12 companies in Houston
Public life sciences companies in Houston
Publicly listed life sciences companies in Houston.
- AlloVirSee in list
Developer of T-cell therapies to treat infectious diseases
Life sciences platforms and tools - CNS PharmaceuticalsSee in list
Developer of treatments for primary and metastatic cancers in the brain and central nervous system
Oncology - Coya TherapeuticsSee in list
Developer of therapeutics for cell therapy and exosome therapy
Immunotherapy - Moleculin BiotechSee in list
Small molecule drugs for leukemia and other cancers
Oncology 
Salarius PharmaBiopharmaceutical firm pioneering targeted protein inhibition and degradation cancer therapies
Oncology
11 companies in Houston
Mobile reach
Top 3 life sciences apps from Houston
The most-installed Android apps published by life sciences companies headquartered in Houston — 202 installs between them. 3 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
1 of 3
Installs119
Rating—
Last updatedApr 2026
Legal entityCognita Labs, LLCdeclared on Google Play
Installs77
Rating—
Last updatedAug 2025
Legal entityCognita Labs, LLCdeclared on Google Play
Installs6
Rating—
Last updatedFeb 2026
Legal entitySPARK BIOMEDICAL INC.declared on Google Play
For investors and data teams
Put this intelligence into your own tools
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
Capital & corporate activity
Life sciences funding and M&A across the United States
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Houston compares. Debt, IPO and grant rounds are excluded.
equity rounds, last 12 months360
US$13.54bn
equity rounds, last 24 months1232
US$37.38bn
raised over five yearsUS$157.58bn
5,603 rounds in the United States
M&A deals, Houston9
last 24 months
Capital by year
amount roundsEquity funding into life sciences in the United States
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
The funding ladder · five years
Rounds and typical cheque by stage
AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years
Most-funded sub-sectors
OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Houston in context
Houston’s share of the United States’s life sciences funding
Equity rounds over the last five years, 317 life sciences companies in Houston among 27,407 in the United States.
Corporate activity · last 24 months
M&A in Houston
5Merger
4Acquisition
Most active acquirers
- Lilly1
- Allianz1
- Eli Lilly and Company1
- Salarius pharmaceuticals1
- Apollo global management1
Most acquired or merged
- CrossBridge Bio2
- Amprion2
- Decoy therapeutics1
- Cara therapeutics1
- Tvardi therapeutics1
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesIndustry landscape report
Life Sciences Industry Landscape of the United States
The financials above are one chapter. The full life sciences landscape of Houston maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
- Market map of every sub-sector
- Funding & company formation by year
- Revenue, profit & financial strength
- Digital footprint: traffic, apps, releases
- Hiring, skills & pay
- Founders & leaders
- News & sentiment
- Where demand runs ahead of supply
Life sciences funding in Houston
75 life sciences companies in Houston have recorded equity funding, US$2.50bn in total. Totals and round dates describe the historical record; they are not current valuations.
Most funded
Largest recorded equity totals, with the latest recorded round.
Life sciences platforms and toolsDeveloping drugs and delivery system along with theranostic imaging primarily for CNS disorders
Recorded equity fundingUS$300.00mSeries D · Oct 2021
Founder · 1
Elias JacksonCo-Founder & President
Professional service robotsDeveloper of a robotic system for endoluminal and single-incision surgery
Recorded equity fundingUS$232.48mSeries D · May 2025
Leadership · 1
Kurt AzarbarzinCEO
Cardiac and vascular disordersDeveloper of devices to lift the burden of heart failure
Recorded equity fundingUS$179.87mSeries C · Dec 2024
Founder · 1
Jacob Kriegel MdCo-Founder & CMO
Life sciences platforms and toolsDeveloper of T-cell therapies to treat infectious diseases
Recorded equity fundingUS$151.25mSeries B · May 2019
Founder · 1
David HallalCo-Founder
ImmunotherapyDeveloper of T cell therapies for the treatment of cancer and chronic infectious diseases
Recorded equity fundingUS$137.53mSeries C · Sep 2014
Leadership · 1
Tom FarrellCEO
OncologyDeveloper of a novel cancer therapy targeting Treg cells
Recorded equity fundingUS$121.40mSeries C · Jul 2025
Founders
Details not available
Cardiac and vascular disordersDeveloping percutaneous mechanical circulatory support for heart failure and cardiorenal syndrome
Recorded equity fundingUS$114.35mSeries E · Feb 2024
Leadership · 1
Eric FainPresident and CEO
OncologyDeveloper of immunotherapeutics for the treatment of cancer
Recorded equity fundingUS$110.76mSeries C · Apr 2025
Leadership · 1
Steve GorlinCEO
OncologyDeveloper of small molecule based therapeutics for cancer treatment
Recorded equity fundingUS$83.00mSeries B · Jun 2021
Founders · 2
David J TweardyCo-Founder & President
Ron DePinhoCo-Founder
OncologyDeveloper of drugs for treating leukemia disease
Recorded equity fundingUS$65.80mSeries A · Jan 2022
Founder · 1
Leo LinbeckFounder
Life sciences platforms and toolsDeveloper of cell-separation technology for regenerative medicine
Recorded equity fundingUS$51.40mSeries D · Feb 2024
Leadership · 1
Michael ColemanEx-President & CEO
GenomicsProvider of genomic services for forensic labs
Recorded equity fundingUS$48.70mSeries B · Feb 2024
Founder · 1
David MittelmanCo-Founder & CEO
ImmunotherapyDeveloper of immunotherapeutic cancer treatments targeting HLA‑G antigen
Recorded equity fundingUS$44.49mSeries A · Sep 2024
Founders · 2
Simon Wain-HobsonCo-Founder & CSO
Pierre DemoyenCo-Founder & Co-CEO
ImmunotherapyDeveloper of therapeutic solutions for treating tumors
Recorded equity fundingUS$44.43mSeries C · Mar 2024
Founder · 1
Michael CurranFounder
ImmunotherapyOncolytic virus platform for treating malignant glioma.
Recorded equity fundingUS$42.96mSeries C · Sep 2018
Leadership · 1
Frank TufaroCEO
Imaging diagnosticsDeveloper of targeted radiopharmaceuticals for cancer diagnosis and treatment
Recorded equity fundingUS$40.00mSeries A · Oct 2022
Founders · 2
Izabela TworowskaCo-Founder & CSO
Azar DelpassandCo-Founder & President
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$300.00m · Series D · Oct 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series D
- Focus
- Drugs, Pain, Research services, Diversified
Founders · 1
Elias JacksonCo-Founder & President
- Highest education
- Philosophy · University Of Texas Medical Branch
Team & hiring signals
LinkedIn headcount311-50
LinkedIn followers177
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 21 (previous snapshot 40)
- Recorded funding
- US$232.48m · Series D · May 2025
- Founded
- 2017 · about 9 years old
- Stage
- Series D
- Focus
- Healthcare, Surgery, Robotic surgery
Funding over time
US$232.48m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Kurt AzarbarzinCEO
Investors · 5
Team & hiring signals
LinkedIn headcount8051-200
LinkedIn followers14,236
Earlier recorded team212021, a different source
Recent company signals
- Partnership Partnership with NVIDIA
Patents
Patent filings135
Focus: Robotic surgical system control, instrumentation, and accessories for minimally invasive procedures.
CPC A61B34/30, A61B34/74, A61B34/37Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 37 (previous snapshot 31)
- Recorded funding
- US$179.87m · Series C · Dec 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutic devices, Congestive heart failure
Funding over time
US$179.87m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jacob Kriegel MdCo-Founder & CMO
- Highest education
- Bachelor's in biology · Columbia University In The City Of New York
Investors · 10
- Gilde HealthcareFund
- Omega FundsFund
- S3 VenturesFund
- ShangBay CapitalFund
- Vensana CapitalFund
Team & hiring signals
LinkedIn headcount5811-50
LinkedIn followers4,606
Technology
- React
- Next.js
- Node.js
- Cloudflare
- Vercel
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 97 (previous snapshot 135)
- Recorded funding
- US$151.25m · Series B · May 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Drugs, Viral, Diversified, Research services
Funding over time
US$151.25m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David HallalCo-Founder
- Highest education
- Bachelor's · University Of New Hampshire
Investors · 9
- EcoR1Fund
- ElevateBioFund
- F2 VenturesFund
- GileadFund
- InvusFund
- Redmile GroupFund
- SVB SecuritiesFund
Team & hiring signals
LinkedIn headcount1351-200
LinkedIn followers9,265
Earlier recorded team972022, a different source
Patents
Patent filings8
Focus: Ex vivo expansion and manufacturing of multivirus-specific T‑cell therapies for transplant immunotherapy
CPC C12M23/24, A61P31/20, A61K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 108
- Recorded funding
- US$137.53m · Series C · Sep 2014
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$137.53m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom FarrellCEO
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Investors · 8
- Redmile GroupFund
- Solasta VenturesFund
- VenBioFund
- RemeditexFund
Team & hiring signals
LinkedIn headcount1811-50
LinkedIn followers9,740
Earlier recorded team1082022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- US$121.40m · Series C · Jul 2025
- Founded
- 2003 · about 23 years old
- Stage
- Series C
- Focus
- Diversified, Drugs
Funding over time
US$121.40m across 2 disclosed equity rounds
Darker bars = larger roundsTeam & hiring signals
LinkedIn headcount1551-200
LinkedIn followers744
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 28
- Recorded funding
- US$114.35m · Series E · Feb 2024
- Founded
- 2005 · about 21 years old
- Stage
- Series E
- Focus
- Medical devices, Therapeutic devices, Congestive heart failure
Funding over time
US$114.35m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Eric FainPresident and CEO
- Highest education
- Doctor of medicine in medicine · Stanford University School Of Medicine
Investors · 4
- Texas.govFund
- Bluebird VenturesFund
Team & hiring signals
LinkedIn headcount2711-50
LinkedIn followers8,876
Patents
Patent filings100
Focus: Percutaneous intravascular blood pumps for mechanical circulatory support and perfusion.
CPC A61M60/139, A61M60/865, F04D3/02Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$110.76m · Series C · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series C
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$110.76m across 4 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Steve GorlinCEO
Team & hiring signals
LinkedIn headcount1551-200
LinkedIn followers744
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Acquirer · 1 deal
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 15
- Recorded funding
- US$83.00m · Series B · Jun 2021
- Founded
- 2017 · about 9 years old
- Stage
- Series B
- Focus
- Drugs, Autoimmune diseases, Diversified
Funding over time
US$83.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
David J TweardyCo-Founder & President
Ron DePinhoCo-Founder
- Highest education
- Doctor of Medicine · Einstein Med
Investors · 3
- Palkon Capital ManagementFund
Team & hiring signals
LinkedIn headcount2011-50
LinkedIn followers2,945
Technology
- AWS
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 2 (previous snapshot 2)
- Recorded funding
- US$65.80m · Series A · Jan 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, Blood cancer
Funding over time
US$65.80m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Leo LinbeckFounder
- Highest education
- MBA · Stanford Graduate School of Business
Investors · 5
- Boxer CapitalFund
- Nextech InvestFund
- OrbimedFund
- Arjun GoyalAngel
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers804
Open roles1of 1 tracked · last posted Feb 2026
- Hiring: Manager/Sr. Manager, Clinical Operations – Oncology · Houston, TX
Recent company signals
- Milestone received FDA Fast Track designation for lead program, a monoclonal antibody for the treatment of relapsed or refractory acute lymphoblastic
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 30
- Recorded funding
- US$51.40m · Series D · Feb 2024
- Founded
- 2005 · about 21 years old
- Stage
- Series D
- Focus
- Research services, Diversified, Drugs
Funding over time
US$51.40m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Michael ColemanEx-President & CEO
Investors · 1
- Sanford HealthFund
Team & hiring signals
LinkedIn headcount1511-50
LinkedIn followers4,118
Recent company signals
- Milestone successful certification under the EU Medical Device Regulation (EU) 2017/745 CE Certification under EU Medical Device Regulation (MDR) 2017
Patents
Patent filings80
Focus: Patents concentrated in chemistry & materials
CPC C12N5/0653, C12N5/0667, A61K35/28Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 22 (previous snapshot 41)
- Recorded funding
- US$48.70m · Series B · Feb 2024
- Founded
- 2018 · about 8 years old
- Stage
- Series B
- Focus
- Applied genomics, Other applications, Legal and forensic genomics
Funding over time
US$48.70m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David MittelmanCo-Founder & CEO
- Highest education
- Doctorates in molecular biophysics · Baylor College Of Medicine
Investors · 1
- GigafundFund
Team & hiring signals
LinkedIn headcount9051-200
LinkedIn followers10,482
Earlier recorded team222021, a different source
Open roles0of 1 tracked · last posted Jan 2025
Patents
Patent filings8
Focus: Secure storage and privacy-preserving processing of genomic data
CPC G06N3/123, G16B40/10Technology
- AWS
- Cloudflare
- Zendesk
- Shopify
- CloudFront
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 25
- Recorded funding
- US$44.49m · Series A · Sep 2024
- Founded
- 2010 · about 16 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Applied genomics, Clinical genomics
Funding over time
US$44.49m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Simon Wain-HobsonCo-Founder & CSO
- Highest education
- Doctorates in biochemistry · University Of Oxford
Pierre DemoyenCo-Founder & Co-CEO
- Highest education
- Institut Pasteur
Investors · 1
- BpifranceFund
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers2,866
Patents
Patent filings4
Focus: Engineered CAR‑T cell immunotherapy targeting HLA‑G antigen
CPC C07K14/7051Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14 (previous snapshot 13)
- Recorded funding
- US$44.43m · Series C · Mar 2024
- Founded
- 2019 · about 7 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Founders · 1
Michael CurranFounder
- Highest education
- Biology · University of Virginia
Team & hiring signals
LinkedIn headcount1611-50
LinkedIn followers1,518
Recent company signals
- Partnership Partnership with BostonGene
- Award SITC 2025 Award Recipients
Patents
Patent filings18
Focus: Targeted hypoxia‑activated prodrugs and STING agonist combos for cancer immunotherapy
CPC A61K31/396, A61K31/675, A61K31/7084Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 11)
- Recorded funding
- US$42.96m · Series C · Sep 2018
- Founded
- 2005 · about 21 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$42.96m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Frank TufaroCEO
- Highest education
- Bachelor's in biology · Mcgill University
Investors · 3
- Mercury FundFund
- MorningsideFund
Team & hiring signals
LinkedIn headcount411-50
LinkedIn followers2,066
Patents
Patent filings81
Focus: Oncolytic adenovirus gene therapies targeting pediatric brain tumors and immune activation
CPC A61K35/761, C12N7/00, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 26 (previous snapshot 33)
- Recorded funding
- US$40.00m · Series A · Oct 2022
- Founded
- 2006 · about 20 years old
- Stage
- Series A
- Focus
- Drugs, Pan cancer, Accessories, Radioisotopes
Founders · 2
Izabela TworowskaCo-Founder & CSO
- Highest education
- Rice University
Azar DelpassandCo-Founder & President
- Highest education
- Bachelor's of science in nursing in nursing · University Of Tehran
Investors · 1
- PortlandFund
Team & hiring signals
LinkedIn headcount4411-50
LinkedIn followers6,206
Open roles1of 1 tracked · last posted Mar 2026
Recent company signals
- Milestone abbreviated New Drug Application (ANDA) FDA approval for generic Ga-68 PSMA-11
Patents
Patent filings65
Focus: Automated production of lead‑212 radionuclide for targeted alpha‑particle cancer therapy
CPC A61K51/0497, A61P35/00, C07H17/07Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Founders and momentum in Houston
Meet the people behind life sciences companies in Houston. 163 of 244 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Growing teams
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Life sciences platforms and toolsAnalytical lab instruments
Team size1,226Up from 814 in the previous snapshot
Founders
Details not available
Healthcare itDeveloper of wearable neurostimulation technology for drug-free opioid withdrawal treatment
Team size18Up from 12 in the previous snapshot
Leadership · 1
Daniel PowellCEO
Diversified diagnosticsGenetic testing and laboratory services for personalized health and ancestry solutions
Team size196Up from 139 in the previous snapshot
Founder · 1
Doron M BeharFounder
Life sciences platforms and toolsBioactive compounds, antibodies, and reagents for life science research
Team size168Up from 128 in the previous snapshot
Founders
Details not available
BiopharmaceuticalsTvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases.
Team size23Up from 18 in the previous snapshot
Founders
Details not available
NephrologyDeveloper of cell-derived therapeutics solutions for the treatment of cardiac health, stroke & kidney transplantation
Team size12Up from 10 in the previous snapshot
Founder · 1
Alexander SchuellerFounder & CEO
Cardiac and vascular disordersDeveloper of devices to lift the burden of heart failure
Team size37Up from 31 in the previous snapshot
Founder · 1
Jacob Kriegel MdCo-Founder & CMO
GenomicsProvider of genetic testing and molecular diagnostics services
Team size254Up from 214 in the previous snapshot
Founders · 2
Tom CaskeyCo-Founder
Art BeaudetCo-Founder
ImmunotherapyOncolytic virus platform for treating malignant glioma.
Team size13Up from 11 in the previous snapshot
Leadership · 1
Frank TufaroCEO
Biopharma outsourcingCompany offering sequencing and PCR based services for assay validation and other clinical trial applications
Team size77Up from 66 in the previous snapshot
Founder · 1
Qin XiangSr. Director/Co Founder
Medical devicesMedical Z is a family-owned company from France whose products have been sold in the USA since 1989 and can be found in more than 35 countries.
Team size37Up from 32 in the previous snapshot
Founders
Details not available
Life sciences techsaleSEER is a clinical data commercialization company.
Team size11Up from 10 in the previous snapshot
Founders
Details not available
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 1,226 (previous snapshot 814)
- Recorded funding
- None recorded
- Founded
- 1995 · about 31 years old
- Stage
- Unfunded
- Focus
- Instruments, Diversified
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 18 (previous snapshot 12)
- Recorded funding
- US$31.23m · Series A · Apr 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Neurological disorders, Therapy, Deaddiction, Opioid management
Funding over time
US$31.23m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Daniel PowellCEO
- Highest education
- Bachelor's in marketing · Texas A&M University
Investors · 2
- Pathway to CuresFund
- Wave VenturesFund
Team & hiring signals
LinkedIn headcount2711-50
LinkedIn followers7,130
Earlier recorded team182022, a different source
Recent company signals
- Award HardTech Awards
- Leadership Hired a Chief Executive Officer
Patents
Patent filings61
Focus: Non‑invasive auricular neurostimulation devices for women's health therapies
CPC A61N1/36036, A61N1/0456, A61N1/36014Mobile apps
- Sparrow Link ParticipantMedical · 6 installs · updated 2026-02-11
Technology
- Cloudflare
- Sentry
- HubSpot
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 196 (previous snapshot 139)
- Recorded funding
- None recorded
- Founded
- 2000 · about 26 years old
- Stage
- Funding Raised
- Focus
- Applied genomics, Multiple application areas
Founders · 1
Doron M BeharFounder
Team & hiring signals
LinkedIn headcount100201-500
LinkedIn followers5,844
Earlier recorded team1962022, a different source
Technology
- AWS
- Cloudflare
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product
- Team size
- 168 (previous snapshot 128)
- Recorded funding
- None recorded
- Founded
- 2005 · about 21 years old
- Stage
- Unfunded
- Focus
- Antibodies, Proteomics, Research reagents and kits
Team & hiring signals
LinkedIn headcount2201,001-5,000
LinkedIn followers4,682
Technology
- AWS
- Java
- Cloudflare
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 23 (previous snapshot 18)
- Recorded funding
- None recorded
- Founded
- 2017 · about 9 years old
- Stage
- Not available
- Focus
- Diversified, Drugs
Team & hiring signals
LinkedIn headcount2011-50
LinkedIn followers2,945
Recent company signals
- Partnership Partnership with Josey Trading
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 12 (previous snapshot 10)
- Recorded funding
- US$15.50m · Seed · Sep 2025
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Drugs, Acute kidney diseases, Diversified, Renal disorders
Funding over time
US$15.50m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Alexander SchuellerFounder & CEO
- Highest education
- PhD · RWTH Aachen University
Investors · 3
- BeiersdorfFund
- KizooFund
- Taiho VenturesFund
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers5,742
Patents
Patent filings10
Focus: Optimizing manufacturing and potency of adoptive immune cell therapies
CPC C12N5/0636, A61K40/42Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 37 (previous snapshot 31)
- Recorded funding
- US$179.87m · Series C · Dec 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutic devices, Congestive heart failure
Funding over time
US$179.87m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jacob Kriegel MdCo-Founder & CMO
- Highest education
- Bachelor's in biology · Columbia University In The City Of New York
Investors · 10
- Gilde HealthcareFund
- Omega FundsFund
- S3 VenturesFund
- ShangBay CapitalFund
- Vensana CapitalFund
Team & hiring signals
LinkedIn headcount5811-50
LinkedIn followers4,606
Technology
- React
- Next.js
- Node.js
- Cloudflare
- Vercel
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 254 (previous snapshot 214)
- Recorded funding
- None recorded
- Founded
- 1978 · about 48 years old
- Stage
- Unfunded
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Founders · 2
Tom CaskeyCo-Founder
Art BeaudetCo-Founder
Team & hiring signals
LinkedIn headcount672501-1,000
LinkedIn followers57,234
Earlier recorded team2542022, a different source
Open roles5of 11 tracked · last posted Jun 2026
Technology
- React
- PHP
- MySQL
- Cloudflare
Salesforce
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 11)
- Recorded funding
- US$42.96m · Series C · Sep 2018
- Founded
- 2005 · about 21 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$42.96m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Frank TufaroCEO
- Highest education
- Bachelor's in biology · Mcgill University
Investors · 3
- Mercury FundFund
- MorningsideFund
Team & hiring signals
LinkedIn headcount411-50
LinkedIn followers2,066
Patents
Patent filings81
Focus: Oncolytic adenovirus gene therapies targeting pediatric brain tumors and immune activation
CPC A61K35/761, C12N7/00, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 77 (previous snapshot 66)
- Recorded funding
- None recorded
- Founded
- 2010 · about 16 years old
- Stage
- Unfunded
- Focus
- Genomics services, Full service, Research services, Genomics
Founders · 1
Qin XiangSr. Director/Co Founder
Team & hiring signals
LinkedIn headcount5851-200
LinkedIn followers4,730
Earlier recorded team772023, a different source
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product
- Team size
- 37 (previous snapshot 32)
- Recorded funding
- None recorded
- Founded
- 1979 · about 47 years old
- Stage
- Not available
- Focus
- Dressing devices, Dressing and wound closure, Medical devices, Medical textiles
Team & hiring signals
LinkedIn headcount3451-200
LinkedIn followers289
Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 11 (previous snapshot 10)
- Recorded funding
- None recorded
- Founded
- 2011 · about 15 years old
- Stage
- Not available
- Focus
- Clinical trials, Patients, Research & development, Scientific sourcing
Team & hiring signals
LinkedIn headcount152-10
LinkedIn followers1,569
Open roles3of 3 tracked · last posted Jun 2026
- Hiring: Head of Data Operations · Texas
- Hiring: Director, Client Success · United States
- Hiring: Director, Client Engagement · United States
Recent company signals
- Leadership Hired a Vice President, Partnerships and Data Strategy
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Women-founded
Life sciences companies in Houston with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
Cardiac and vascular disordersDeveloper of devices to lift the burden of heart failure
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Jacob Kriegel MdCo-Founder & CMO
Imaging diagnosticsDeveloper of targeted radiopharmaceuticals for cancer diagnosis and treatment
Revenue modelFee-for-service
Founders · 2
Izabela TworowskaCo-Founder & CSO
Azar DelpassandCo-Founder & President
OncologyDeveloper of minimally invasive lung tissue excision tool for lung cancer
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Joanna NathanFounder & CEO
OrthopedicsA handheld device that enables accurate spinal-needle placement for lumbar punctures
Revenue modelSubscription
Founders · 4
Jessica TraverCo-Founder & CEO
Nicole MoskowitzCo-Founder & CTO
Xavier Garcia-RojasCo-Founder & CMO
Yashar GanjehCo-Founder & VP
OncologyDeveloper of cancer therapies for targeting cancer-associated fibroblasts
Revenue modelFee-for-service
Founders · 3
Rosa HwangCo-Founder
Ronald DePinhoFounder
Emmanuelle SchulerFounder & CEO
OncologyDeveloper of gene therapies for rare cancers and autoimmune diseases
Revenue modelFee-for-service
Founder · 1
Lynn ZechiedrichFounder & CEO
OncologyDeveloper of CAR-T cell therapies for malignancies
Revenue modelFee-for-service
Founders · 3
Max MamonkinCo-Founder and CSO
Sarah HeinCo-Founder & CEO
Malcolm BrennerCo-Founder
PulmonologyDeveloper of a medical device for mechanical ventilation
Revenue modelE-commerce - product / Physical commerce
Founders · 2
Mehdi RazaviCo-Founder
Elizabeth JaworskiCo-Founder & CEO
NeurologyDeveloper of nature-made catalytic antibodies for therapeutic and vaccine applications
Revenue modelPhysical commerce
Founder · 1
Sudhir PaulCo-Founder
OncologyTech-enabled device to prevent side effects from cancer treatment
Revenue modelE-commerce - product / Physical commerce
Founders
Details not available
ToxicologyDeveloper of vaccine that prevents fentanyl from entering the brain
Revenue modelE-commerce - product / Physical commerce
Founders · 5
JR RahnCo-Founder
Collin GageCo-Founder & CEO
Colin HaileCo-Founder
David DowlingCo-Founder
Ofer LevyCo-founder Ovax, Inc
Life sciences platforms and toolsProvider of patient-derived organoids (PDOs) to accelerate drug development for rare cancers
Revenue modelSubscription
Founders · 2
Preethi SamuelCo-Founder
Bhuvanesh DaveCo-Founder
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 37 (previous snapshot 31)
- Recorded funding
- US$179.87m · Series C · Dec 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutic devices, Congestive heart failure
Funding over time
US$179.87m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jacob Kriegel MdCo-Founder & CMO
- Highest education
- Bachelor's in biology · Columbia University In The City Of New York
Investors · 10
- Gilde HealthcareFund
- Omega FundsFund
- S3 VenturesFund
- ShangBay CapitalFund
- Vensana CapitalFund
Team & hiring signals
LinkedIn headcount5811-50
LinkedIn followers4,606
Technology
- React
- Next.js
- Node.js
- Cloudflare
- Vercel
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 26 (previous snapshot 33)
- Recorded funding
- US$40.00m · Series A · Oct 2022
- Founded
- 2006 · about 20 years old
- Stage
- Series A
- Focus
- Drugs, Pan cancer, Accessories, Radioisotopes
Founders · 2
Izabela TworowskaCo-Founder & CSO
- Highest education
- Rice University
Azar DelpassandCo-Founder & President
- Highest education
- Bachelor's of science in nursing in nursing · University Of Tehran
Investors · 1
- PortlandFund
Team & hiring signals
LinkedIn headcount4411-50
LinkedIn followers6,206
Open roles1of 1 tracked · last posted Mar 2026
Recent company signals
- Milestone abbreviated New Drug Application (ANDA) FDA approval for generic Ga-68 PSMA-11
Patents
Patent filings65
Focus: Automated production of lead‑212 radionuclide for targeted alpha‑particle cancer therapy
CPC A61K51/0497, A61P35/00, C07H17/07Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 9 (previous snapshot 5)
- Recorded funding
- US$6.00m · Series A · Jun 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Medical devices, Imaging, Lung cancer
Funding over time
US$6.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Joanna NathanFounder & CEO
Investors · 9
GenHenn CapitalFund
New World AngelsFund
Science CenterFund
cultivate(MD)Fund
Patents
Patent filings27
Focus: Advanced control and sealing systems for minimally invasive thoracic tissue resection.
CPC A61B17/32053, A61B18/082, A61B17/320092Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 6 (previous snapshot 10)
- Recorded funding
- US$5.50m · Series A · Jul 2021
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Medical devices, Surgical tools
Founders · 4
Jessica TraverCo-Founder & CEO
- Highest education
- Bachelor's in mechanical engineering · Purdue University
Nicole MoskowitzCo-Founder & CTO
Xavier Garcia-RojasCo-Founder & CMO
Yashar GanjehCo-Founder & VP
- Highest education
- Master's of science in mechanical engineering · University Of Michigan
Investors · 2
The Pink CeilingFund
Curate CapitalFund
Team & hiring signals
LinkedIn headcount92-10
LinkedIn followers1,359
Open roles1of 1 tracked · last posted May 2026
- Hiring: Sales Territory Executive - Medical Device · Chicago, Illinois
Recent company signals
- Partnership Partnership with Atrium Health
- Launch Launched VerTouch+ (imagers)
Technology
- Google Cloud
- React
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 5
- Recorded funding
- US$15.50m · Series A · Jun 2021
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Founders · 3
Rosa HwangCo-Founder
Ronald DePinhoFounder
Emmanuelle SchulerFounder & CEO
Investors · 1
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers323
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 3
- Recorded funding
- US$1.62m · Seed · Aug 2023
- Founded
- 2013 · about 13 years old
- Stage
- Seed
- Focus
- Enabling technologies, Technology platforms, Gene delivery, Nanoenabled products
Funding over time
US$1.62m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Lynn ZechiedrichFounder & CEO
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- US$33.20m · Series A · Oct 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$33.20m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Max MamonkinCo-Founder and CSO
Sarah HeinCo-Founder & CEO
- Highest education
- Doctor of Philosophy, Biology · Baylor College of Medicine
Malcolm BrennerCo-Founder
Investors · 11
- 4Bio CapitalFund
- AlexandriaFund
- KdT VenturesFund
- Mansueto OfficeFund
- Modi VenturesFund
Team & hiring signals
LinkedIn headcount242-10
LinkedIn followers4,262
Open roles1of 1 tracked · last posted Dec 2025
- Hiring: Clinical Sample & Logistics Specialist · Houston, Texas
Recent company signals
- Leadership Hired a Chief Business Officer
- Milestone regulatory update regulatory update
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 8
- Recorded funding
- None recorded
- Founded
- 2021 · about 5 years old
- Stage
- Seed
- Focus
- Medical devices, Therapeutic devices, Artificial ventilation, Invasive ventilation
Founders · 2
Mehdi RazaviCo-Founder
Elizabeth JaworskiCo-Founder & CEO
- Highest education
- Bachelor's of Science, Entomology · University of Florida
Investors · 1
HAXFund
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers373
Recent company signals
- Award NSF STTR Phase I grant for the development of a Tracheal Phrenic Nerve Stimulation Device — National Science Foundation (NSF)
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 3
- Recorded funding
- None recorded
- Founded
- 2010 · about 16 years old
- Stage
- Funding Raised
- Focus
- Diversified, Drugs, Neurodegenerative
Founders · 1
Sudhir PaulCo-Founder
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 1
- Recorded funding
- None recorded
- Founded
- 2020 · about 6 years old
- Stage
- Funding Raised
- Focus
- Medical devices, Therapies, Chemotherapy, Therapy complications
Team & hiring signals
LinkedIn headcount5
LinkedIn followers193
Recent company signals
- Award SuperCrowd Award — Superpowers for Good Live Pitch
Patents
Patent filings13
Focus: Wearable temperature-regulating devices to prevent chemotherapy-induced side effects
CPC A61F7/00, A61F7/0085, A61F7/02Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Diversified, Drugs
Founders · 5
JR RahnCo-Founder
Collin GageCo-Founder & CEO
Colin HaileCo-Founder
David DowlingCo-Founder
Ofer LevyCo-founder Ovax, Inc
- Highest education
- Doctor of medicine in microbiology · New York University School Of Medicine
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2017 · about 9 years old
- Stage
- Unfunded
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Founders · 2
Preethi SamuelCo-Founder
Bhuvanesh DaveCo-Founder
- Highest education
- St. Gabriel'S Academy, Roorkee - 247667 U.K
Team & hiring signals
LinkedIn headcount111-50
LinkedIn followers513
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Recently founded
Life sciences companies in Houston founded in the last four years, newest first.
NeurologyDeveloper of therapeutics for longevity-related diseases
Founded2024Seed
Founders · 2
GottliebCo-Founder
Thomas KimCo-Founder & CEO
OncologyDeveloper of therapeutics for cancer treatment
Founded2024Series A
Founders
Details not available
NeurologyDeveloper of an assay to identify tumor cells in the central nervous system
Founded2024Unfunded
Founders
Details not available
Life sciences techDeveloper of generative AI based RNAstate research platform to predict future omics states
Founded2023Series A
Founders · 2
Ashwin GopinathCo-Founder & CTO
David ZhangCo-Founder & CEO
Sleep medicineEmber Sleep is a company that creates a sleep apnea treatment platform to help people improve their sleep quality.
Founded2023Private
Founders
Details not available
ToxicologyDeveloper of vaccine that prevents fentanyl from entering the brain
Founded2023Unfunded
Founders · 5
JR RahnCo-Founder
Collin GageCo-Founder & CEO
Colin HaileCo-Founder
David DowlingCo-Founder
Ofer LevyCo-founder Ovax, Inc
Cardiac and vascular disordersDeveloper of minimally invasive catheter solutions for patients with aortic aneurysms
Founded2023Unfunded
Founders · 2
Melanie LowtherCo-Founder
Matthew KuhnCo-Founder & CEO
Microbiome therapeuticsDeveloper of therapeutics derived from bacteriophage
Founded2023Unfunded
Leadership · 1
Amanda BurkardtCEO
OncologyDeveloper of radiopharmaceuticals for the treatment of cancer
Founded2023Seed
Founders
Details not available
Cannabis healthtechDeveloper of therapeutics for mental health and wellness
Founded2023Unfunded
Leadership · 1
Robert YrshusCEO & Executive Chairman
Life sciences techAI based platform for patient recruitment
Founded2023Unfunded
Founders
Details not available
ImmunotherapyDeveloper of antibody therapeutics for the treatment of cancer
Founded2023Unfunded
Founders
Details not available
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$365k · Seed · Jun 2025
- Founded
- 2024 · about 2 years old
- Stage
- Seed
- Focus
- Diversified, Drugs, Neurodegenerative
Founders · 2
GottliebCo-Founder
Thomas KimCo-Founder & CEO
Team & hiring signals
LinkedIn headcount32-10
LinkedIn followers221
Recent company signals
- Partnership Partnership with MD Anderson
- Award 6 Finalists
- Award 2025 Startup Spotlight — EBD Group and BIO-Europe
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$4.00m · Series A · Apr 2025
- Founded
- 2024 · about 2 years old
- Stage
- Series A
- Focus
- Diversified, Drugs
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Diversified, In-vitro diagnostic tests, In-vitro diagnostics
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$16.00m · Series A · Apr 2025
- Founded
- 2023 · about 3 years old
- Stage
- Series A
- Focus
- Research & development, Medical ai data validation
Funding over time
US$16.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Ashwin GopinathCo-Founder & CTO
- Highest education
- PhD · Boston University
David ZhangCo-Founder & CEO
- Highest education
- University of Michigan
Investors · 10
- AccelFund
- CatapultFund
- GaingelsFund
- Mana VenturesFund
- CaltechFund
- Dario AmodeiAngel
Team & hiring signals
LinkedIn headcount2651-200
LinkedIn followers13,533
Recent company signals
- Partnership Partnership with Earendil Labs
Patents
Patent filings7
Focus: AI‑enhanced nucleic‑acid analysis and microfluidic blood cell separation for biomarker quantification
CPC C12N15/1096, G06N20/00, G16H50/20Technology
- React
- Next.js
- Node.js
- Vercel
- Tailwind CSS
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 3
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Private
- Focus
- Medical device, Medical devices, Sleep inducing devices, Therapeutic devices
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Diversified, Drugs
Founders · 5
JR RahnCo-Founder
Collin GageCo-Founder & CEO
Colin HaileCo-Founder
David DowlingCo-Founder
Ofer LevyCo-founder Ovax, Inc
- Highest education
- Doctor of medicine in microbiology · New York University School Of Medicine
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Medical devices, Therapeutic devices, Vascular access and closure
Founders · 2
Melanie LowtherCo-Founder
- Highest education
- University of Georgia
Matthew KuhnCo-Founder & CEO
Team & hiring signals
LinkedIn headcount32-10
LinkedIn followers628
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Drugs
Leadership · 1
Amanda BurkardtCEO
- Highest education
- Master's of Science · Oklahoma State University
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers1,759
Recent company signals
- Award Top 10 Most Promising Life Science Companies — Texas Life Science Forum
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Drugs, Diversified, Radiopharmaceuticals
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers325
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Drugs, Psychiatric, Diversified, Psychedelics
Leadership · 1
Robert YrshusCEO & Executive Chairman
Team & hiring signals
LinkedIn headcount411-50
LinkedIn followers178
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Research & development, Clinical trials, Scientific sourcing, Patients
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Drugs, Diversified, Immuno oncology
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Most covered in the news
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
ImmunotherapyDeveloper of therapeutics for cell therapy and exosome therapy
News events · last 24 months34Across tracked business press
Founder · 1
Howard BermanCo-Founder & CEO
NeurologyVagus nerve stimulation device for epilepsy and treatment resistant depression
News events · last 24 months29Across tracked business press
Founders
Details not available
OncologyDeveloper of treatments for primary and metastatic cancers in the brain and central nervous system
News events · last 24 months29Across tracked business press
Leadership · 1
John ClimacoCEO
OncologySmall molecule drugs for leukemia and other cancers
News events · last 24 months25Across tracked business press
Founder · 1
Wally KlempFounder & CEO
OncologyDeveloper of therapeutics for the treatment of cancer
News events · last 24 months16Across tracked business press
Founder · 1
Peter NielsenFounder & CEO
ImmunotherapyDeveloper of T-cell based therapeutics for cancer treatment
News events · last 24 months14Across tracked business press
Leadership · 1
Peter HoangCEO & President
Cardiac and vascular disordersDeveloper of devices to lift the burden of heart failure
News events · last 24 months10Across tracked business press
Founder · 1
Jacob Kriegel MdCo-Founder & CMO
ImmunotherapyDeveloper of interleukin-4 Receptor (IL4R) targeted cytokines for cancer
News events · last 24 months10Across tracked business press
Leadership · 1
Fahar MerchantPresident & CEO
ImmunotherapyDeveloper of T cell therapies for the treatment of cancer and chronic infectious diseases
News events · last 24 months7Across tracked business press
Leadership · 1
Tom FarrellCEO
OncologyDeveloper of minimally invasive lung tissue excision tool for lung cancer
News events · last 24 months7Across tracked business press
Founder · 1
Joanna NathanFounder & CEO
Life sciences platforms and toolsDeveloper of T-cell therapies to treat infectious diseases
News events · last 24 months6Across tracked business press
Founder · 1
David HallalCo-Founder
OncologyDeveloper of CAR-T cell therapies for malignancies
News events · last 24 months6Across tracked business press
Founders · 3
Max MamonkinCo-Founder and CSO
Sarah HeinCo-Founder & CEO
Malcolm BrennerCo-Founder
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 6 (previous snapshot 10)
- Recorded funding
- US$20.44m · Series A · May 2022
- Founded
- 2020 · about 6 years old
- Stage
- Public
- Focus
- Drugs, Neurodegenerative, Diversified, Immuno oncology
Funding over time
US$20.44m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Howard BermanCo-Founder & CEO
- Highest education
- Bachelor's's degree, Biology/Biological Sciences, General · University of Michigan
Team & hiring signals
LinkedIn headcount182-10
LinkedIn followers5,805
Earlier recorded team62022, a different source
Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
HardwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, E-commerce - product, Physical commerce
- Team size
- 660
- Recorded funding
- None recorded
- Founded
- 1987 · about 39 years old
- Stage
- Public
- Focus
- Medical devices, Therapeutic devices, Epilepsy
Patents
Patent filings740
Focus: Implantable vagus nerve stimulation devices for cardiac, sleep‑apnea, and epilepsy therapy
CPC A61N1/36139, A61N1/36114, A61N1/36082Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 5 (previous snapshot 7)
- Recorded funding
- US$22.52m · Series B · May 2026
- Founded
- 2017 · about 9 years old
- Stage
- Public
- Focus
- Drugs, Brain cancer
Leadership · 1
John ClimacoCEO
Team & hiring signals
LinkedIn headcount132-10
LinkedIn followers2,188
Earlier recorded team52021, a different source
Open roles1of 1 tracked · last posted May 2026
- Hiring: AD/Director, Business Development
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 19 (previous snapshot 21)
- Recorded funding
- US$9.69m · Series A · Jun 2013
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Funding over time
US$9.69m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Wally KlempFounder & CEO
Team & hiring signals
LinkedIn headcount222-10
LinkedIn followers5,049
Earlier recorded team192022, a different source
Open roles1of 1 tracked · last posted Apr 2026
Recent company signals
- Milestone 50% and 57% in Annamycin dose arms of Phase 2/3 MIRACLE trial, compared with 29% for control arm Composite complete remission (CRc)
Patents
Patent filings37
Focus: Liposomal formulation and lyophilized delivery of the anticancer agent annamycin.
CPC A61K31/704, A61K9/0019, A61K31/70Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 10
- Recorded funding
- None recorded
- Founded
- 2000 · about 26 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Drugs
Founders · 1
Peter NielsenFounder & CEO
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 67 (previous snapshot 67)
- Recorded funding
- None recorded
- Founded
- 1991 · about 35 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Leadership · 1
Peter HoangCEO & President
- Highest education
- BA, Biochemistry · Yale University
Team & hiring signals
LinkedIn headcount2211-50
LinkedIn followers4,907
Earlier recorded team672022, a different source
Recent company signals
- Leadership Hired a Board of Directors
Technology
- PHP
- MySQL
- WordPress
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 37 (previous snapshot 31)
- Recorded funding
- US$179.87m · Series C · Dec 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Medical devices, Therapeutic devices, Congestive heart failure
Funding over time
US$179.87m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jacob Kriegel MdCo-Founder & CMO
- Highest education
- Bachelor's in biology · Columbia University In The City Of New York
Investors · 10
- Gilde HealthcareFund
- Omega FundsFund
- S3 VenturesFund
- ShangBay CapitalFund
- Vensana CapitalFund
Team & hiring signals
LinkedIn headcount5811-50
LinkedIn followers4,606
Technology
- React
- Next.js
- Node.js
- Cloudflare
- Vercel
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 1
- Recorded funding
- None recorded
- Founded
- 2012 · about 14 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Leadership · 1
Fahar MerchantPresident & CEO
Team & hiring signals
LinkedIn headcount2211-50
LinkedIn followers4,653
Earlier recorded team12022, a different source
Recent company signals
- Milestone 100+ patents issued
- Milestone Phase 1b randomized trial evaluating MDNA11 in neoadjuvant setting for Stage III cutaneous #melanoma at up to 12 centers in Italy
Technology
- Google Cloud
- PHP
- MySQL
- Nginx
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 108
- Recorded funding
- US$137.53m · Series C · Sep 2014
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$137.53m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom FarrellCEO
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Investors · 8
- Redmile GroupFund
- Solasta VenturesFund
- VenBioFund
- RemeditexFund
Team & hiring signals
LinkedIn headcount1811-50
LinkedIn followers9,740
Earlier recorded team1082022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 9 (previous snapshot 5)
- Recorded funding
- US$6.00m · Series A · Jun 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Medical devices, Imaging, Lung cancer
Funding over time
US$6.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Joanna NathanFounder & CEO
Investors · 9
- GenHenn CapitalFund
- New World AngelsFund
- Science CenterFund
- cultivate(MD)Fund
Patents
Patent filings27
Focus: Advanced control and sealing systems for minimally invasive thoracic tissue resection.
CPC A61B17/32053, A61B18/082, A61B17/320092Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 97 (previous snapshot 135)
- Recorded funding
- US$151.25m · Series B · May 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Drugs, Viral, Diversified, Research services
Funding over time
US$151.25m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David HallalCo-Founder
- Highest education
- Bachelor's · University Of New Hampshire
Investors · 9
- EcoR1Fund
- ElevateBioFund
- F2 VenturesFund
- GileadFund
- InvusFund
- Redmile GroupFund
- SVB SecuritiesFund
Team & hiring signals
LinkedIn headcount1351-200
LinkedIn followers9,265
Earlier recorded team972022, a different source
Patents
Patent filings8
Focus: Ex vivo expansion and manufacturing of multivirus-specific T‑cell therapies for transplant immunotherapy
CPC C12M23/24, A61P31/20, A61K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- US$33.20m · Series A · Oct 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$33.20m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Max MamonkinCo-Founder and CSO
Sarah HeinCo-Founder & CEO
- Highest education
- Doctor of Philosophy, Biology · Baylor College of Medicine
Malcolm BrennerCo-Founder
Investors · 11
- 4Bio CapitalFund
- AlexandriaFund
- KdT VenturesFund
- Mansueto OfficeFund
- Modi VenturesFund
Team & hiring signals
LinkedIn headcount242-10
LinkedIn followers4,262
Open roles1of 1 tracked · last posted Dec 2025
- Hiring: Clinical Sample & Logistics Specialist · Houston, Texas
Recent company signals
- Leadership Hired a Chief Business Officer
- Milestone regulatory update regulatory update
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore Houston life sciences companies by sub-sector
The most common specialisations among life sciences companies in Houston. Open a company to see what it sells, who runs it and how far it has come.
Oncology · 63
63 life sciences companies in Houston work in oncology. Shown: the best-documented.
ImmunotherapyDeveloper of T cell therapies for the treatment of cancer and chronic infectious diseases
Revenue modelPhysical commerce
Leadership · 1
Tom FarrellCEO
Imaging diagnosticsDeveloper of targeted radiopharmaceuticals for cancer diagnosis and treatment
Revenue modelFee-for-service
Founders · 2
Izabela TworowskaCo-Founder & CSO
Azar DelpassandCo-Founder & President
ImmunotherapyDeveloper of immunotherapeutic cancer treatments targeting HLA‑G antigen
Revenue modelPhysical commerce
Founders · 2
Simon Wain-HobsonCo-Founder & CSO
Pierre DemoyenCo-Founder & Co-CEO
OncologySmall molecule drugs for leukemia and other cancers
Revenue modelPhysical commerce
Founder · 1
Wally KlempFounder & CEO
OncologyDeveloper of small molecule based therapeutics for cancer treatment
Revenue modelE-commerce - product / Physical commerce
Founders · 2
David J TweardyCo-Founder & President
Ron DePinhoCo-Founder
ImmunotherapyDeveloper of therapeutic solutions for treating tumors
Revenue modelFee-for-service
Founder · 1
Michael CurranFounder
ImmunotherapyOncolytic virus platform for treating malignant glioma.
Revenue modelSubscription
Leadership · 1
Frank TufaroCEO
OncologyBiopharmaceutical firm pioneering targeted protein inhibition and degradation cancer therapies
Revenue modelPhysical commerce
Leadership · 1
David ArthurCEO & Director
OncologyDeveloper of therapeutics for the treatment of cancer
Revenue modelPhysical commerce
Leadership · 1
Rahul ArasCEO & President
OncologyDeveloper of minimally invasive lung tissue excision tool for lung cancer
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Joanna NathanFounder & CEO
NanotechnologyDeveloper of nanoparticle-based cancer treatment for solid tumors
Revenue modelPhysical commerce
Leadership · 1
David JordenInterim CEO & Bord of Directors
ImmunotherapyBiotech targeting cellular metabolism for novel anti-cancer and anti-fibrosis therapies
Revenue modelSubscription
Leadership · 1
Dean WelschCEO
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 108
- Recorded funding
- US$137.53m · Series C · Sep 2014
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$137.53m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom FarrellCEO
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Investors · 8
- Redmile GroupFund
- Solasta VenturesFund
- VenBioFund
- RemeditexFund
Team & hiring signals
LinkedIn headcount1811-50
LinkedIn followers9,740
Earlier recorded team1082022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 26 (previous snapshot 33)
- Recorded funding
- US$40.00m · Series A · Oct 2022
- Founded
- 2006 · about 20 years old
- Stage
- Series A
- Focus
- Drugs, Pan cancer, Accessories, Radioisotopes
Founders · 2
Izabela TworowskaCo-Founder & CSO
- Highest education
- Rice University
Azar DelpassandCo-Founder & President
- Highest education
- Bachelor's of science in nursing in nursing · University Of Tehran
Investors · 1
- PortlandFund
Team & hiring signals
LinkedIn headcount4411-50
LinkedIn followers6,206
Open roles1of 1 tracked · last posted Mar 2026
Recent company signals
- Milestone abbreviated New Drug Application (ANDA) FDA approval for generic Ga-68 PSMA-11
Patents
Patent filings65
Focus: Automated production of lead‑212 radionuclide for targeted alpha‑particle cancer therapy
CPC A61K51/0497, A61P35/00, C07H17/07Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 25
- Recorded funding
- US$44.49m · Series A · Sep 2024
- Founded
- 2010 · about 16 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Applied genomics, Clinical genomics
Funding over time
US$44.49m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Simon Wain-HobsonCo-Founder & CSO
- Highest education
- Doctorates in biochemistry · University Of Oxford
Pierre DemoyenCo-Founder & Co-CEO
- Highest education
- Institut Pasteur
Investors · 1
- BpifranceFund
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers2,866
Patents
Patent filings4
Focus: Engineered CAR‑T cell immunotherapy targeting HLA‑G antigen
CPC C07K14/7051Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 19 (previous snapshot 21)
- Recorded funding
- US$9.69m · Series A · Jun 2013
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Funding over time
US$9.69m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Wally KlempFounder & CEO
Team & hiring signals
LinkedIn headcount222-10
LinkedIn followers5,049
Earlier recorded team192022, a different source
Open roles1of 1 tracked · last posted Apr 2026
Recent company signals
- Milestone 50% and 57% in Annamycin dose arms of Phase 2/3 MIRACLE trial, compared with 29% for control arm Composite complete remission (CRc)
Patents
Patent filings37
Focus: Liposomal formulation and lyophilized delivery of the anticancer agent annamycin.
CPC A61K31/704, A61K9/0019, A61K31/70Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Acquirer · 1 deal
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 15
- Recorded funding
- US$83.00m · Series B · Jun 2021
- Founded
- 2017 · about 9 years old
- Stage
- Series B
- Focus
- Drugs, Autoimmune diseases, Diversified
Funding over time
US$83.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
David J TweardyCo-Founder & President
Ron DePinhoCo-Founder
- Highest education
- Doctor of Medicine · Einstein Med
Investors · 3
- Palkon Capital ManagementFund
Team & hiring signals
LinkedIn headcount2011-50
LinkedIn followers2,945
Technology
- AWS
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14 (previous snapshot 13)
- Recorded funding
- US$44.43m · Series C · Mar 2024
- Founded
- 2019 · about 7 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Founders · 1
Michael CurranFounder
- Highest education
- Biology · University of Virginia
Team & hiring signals
LinkedIn headcount1611-50
LinkedIn followers1,518
Recent company signals
- Partnership Partnership with BostonGene
- Award SITC 2025 Award Recipients
Patents
Patent filings18
Focus: Targeted hypoxia‑activated prodrugs and STING agonist combos for cancer immunotherapy
CPC A61K31/396, A61K31/675, A61K31/7084Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 11)
- Recorded funding
- US$42.96m · Series C · Sep 2018
- Founded
- 2005 · about 21 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$42.96m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Frank TufaroCEO
- Highest education
- Bachelor's in biology · Mcgill University
Investors · 3
- Mercury FundFund
- MorningsideFund
Team & hiring signals
LinkedIn headcount411-50
LinkedIn followers2,066
Patents
Patent filings81
Focus: Oncolytic adenovirus gene therapies targeting pediatric brain tumors and immune activation
CPC A61K35/761, C12N7/00, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Acquirer · 1 deal
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 12
- Recorded funding
- US$108k · Seed · Mar 2013
- Founded
- 2010 · about 16 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Leadership · 1
David ArthurCEO & Director
- Highest education
- MBA · Duke University
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers2,757
Earlier recorded team122023, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 10 (previous snapshot 12)
- Recorded funding
- US$28.82m · Series B · Feb 2021
- Founded
- 2010 · about 16 years old
- Stage
- Series B
- Focus
- Drugs, Pan cancer
Funding over time
US$28.82m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Rahul ArasCEO & President
Investors · 7
- GOOSEFund
- Lumira VenturesFund
- SanteFund
- Sante VenturesFund
Team & hiring signals
LinkedIn headcount1611-50
LinkedIn followers2,781
Recent company signals
- Milestone Phase 1 clinical data presented at ASCO Annual Meeting
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 9 (previous snapshot 5)
- Recorded funding
- US$6.00m · Series A · Jun 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Medical devices, Imaging, Lung cancer
Funding over time
US$6.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Joanna NathanFounder & CEO
Investors · 9
- GenHenn CapitalFund
- New World AngelsFund
- Science CenterFund
- cultivate(MD)Fund
Patents
Patent filings27
Focus: Advanced control and sealing systems for minimally invasive thoracic tissue resection.
CPC A61B17/32053, A61B18/082, A61B17/320092Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 9 (previous snapshot 2)
- Recorded funding
- US$24.52m · Series B · Mar 2023
- Founded
- 2002 · about 24 years old
- Stage
- Series B
- Focus
- Medical devices, Therapies, Radiation therapy, Nanoenabled products
Funding over time
US$24.52m across 11 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
David JordenInterim CEO & Bord of Directors
Investors · 1
- Sirtex MedicalFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers292
Earlier recorded team92020, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 9
- Recorded funding
- US$11.04m · Series B · Jan 2026
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$11.04m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Dean WelschCEO
- Highest education
- BS, ACS Approved, Chemistry · Hope College
Investors · 4
- InterVestFund
- Mirae Asset VentureFund
- NHN InvestmentFund
Team & hiring signals
LinkedIn headcount62-10
LinkedIn followers435
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences platforms and tools · 43
43 life sciences companies in Houston work in life sciences platforms and tools. Shown: the best-documented.
Life sciences platforms and toolsDeveloper of T-cell therapies to treat infectious diseases
Revenue modelFee-for-service
Founder · 1
David HallalCo-Founder
Life sciences platforms and toolsProvides services to store adult stem cells for medical treatments
Revenue modelCommission on transaction / Fee-for-service
Founder · 1
Stanley JonesCo-Founder & CMO
Life sciences platforms and toolsDeveloper of cell-separation technology for regenerative medicine
Revenue modelFee-for-service
Leadership · 1
Michael ColemanEx-President & CEO
Life sciences platforms and toolsDeveloper of point of care diagnostic technology for automation of Enzyme Immunoassay
Revenue modelPhysical commerce
Founder · 1
Dev ChatterjeeCo-Founder & Director of Research
3d printingIn-vitro cell culture technology using 3D magnetic bioprinting
Revenue modelFee-for-service
Founder · 1
David J. LeeCo-Founder
Life sciences platforms and toolsDeveloping drugs and delivery system along with theranostic imaging primarily for CNS disorders
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Elias JacksonCo-Founder & President
Life sciences platforms and toolsDeveloper of enzymes and a cofactor for therapeutic use
Revenue modelPhysical commerce
Leadership · 1
Keith KleemanCEO
Life sciences platforms and toolsAnalytical lab instruments
Revenue modelSubscription
Founders
Details not available
GenomicsProvider of genetic testing and molecular diagnostics services
Revenue modelFee-for-service
Founders · 2
Tom CaskeyCo-Founder
Art BeaudetCo-Founder
Life sciences platforms and toolsBioactive compounds, antibodies, and reagents for life science research
Revenue modelE-commerce - product
Founders
Details not available
Biopharma outsourcingCompany offering sequencing and PCR based services for assay validation and other clinical trial applications
Revenue modelFee-for-service
Founder · 1
Qin XiangSr. Director/Co Founder
Life sciences platforms and toolsGlobal imaging core lab and CRO providing expert image analysis
Revenue modelFee-for-service
Founder · 1
John HippFounder & CSO
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 97 (previous snapshot 135)
- Recorded funding
- US$151.25m · Series B · May 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Drugs, Viral, Diversified, Research services
Funding over time
US$151.25m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David HallalCo-Founder
- Highest education
- Bachelor's · University Of New Hampshire
Investors · 9
- EcoR1Fund
- ElevateBioFund
- F2 VenturesFund
- GileadFund
- InvusFund
- Redmile GroupFund
- SVB SecuritiesFund
Team & hiring signals
LinkedIn headcount1351-200
LinkedIn followers9,265
Earlier recorded team972022, a different source
Patents
Patent filings8
Focus: Ex vivo expansion and manufacturing of multivirus-specific T‑cell therapies for transplant immunotherapy
CPC C12M23/24, A61P31/20, A61K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, Fee-for-service
- Team size
- 34 (previous snapshot 39)
- Recorded funding
- US$34.06m · Series B · Jul 2012
- Founded
- 2011 · about 15 years old
- Stage
- Series B
- Focus
- Research services, Biorepository
Founders · 1
Stanley JonesCo-Founder & CMO
- Highest education
- Doctor of medicine in medicine · Ut Southwestern Medical Center
Team & hiring signals
LinkedIn headcount3311-50
LinkedIn followers3,952
Earlier recorded team342022, a different source
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 30
- Recorded funding
- US$51.40m · Series D · Feb 2024
- Founded
- 2005 · about 21 years old
- Stage
- Series D
- Focus
- Research services, Diversified, Drugs
Funding over time
US$51.40m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Michael ColemanEx-President & CEO
Investors · 1
- Sanford HealthFund
Team & hiring signals
LinkedIn headcount1511-50
LinkedIn followers4,118
Recent company signals
- Milestone successful certification under the EU Medical Device Regulation (EU) 2017/745 CE Certification under EU Medical Device Regulation (MDR) 2017
Patents
Patent filings80
Focus: Patents concentrated in chemistry & materials
CPC C12N5/0653, C12N5/0667, A61K35/28Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 12
- Recorded funding
- US$2.66m · Seed · Dec 2021
- Founded
- 2013 · about 13 years old
- Stage
- Seed
- Focus
- Instruments, Microfluidics, Lab on a chip
Founders · 1
Dev ChatterjeeCo-Founder & Director of Research
Patents
Patent filings2
Focus: Point‑of‑care microfluidic diagnostic devices using discontinuous fluidic systems
CPC G01N33/54333Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 4
- Recorded funding
- US$250k · Seed · Jun 2010
- Founded
- 2008 · about 18 years old
- Stage
- Seed
- Focus
- Applications, Healthcare, Tissue engineering, Research services
Founders · 1
David J. LeeCo-Founder
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers534
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$300.00m · Series D · Oct 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series D
- Focus
- Drugs, Pain, Research services, Diversified
Founders · 1
Elias JacksonCo-Founder & President
- Highest education
- Philosophy · University Of Texas Medical Branch
Team & hiring signals
LinkedIn headcount311-50
LinkedIn followers177
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- Not available
- Recorded funding
- US$598k · Seed · Mar 2026
- Founded
- 2010 · about 16 years old
- Stage
- Seed
- Focus
- Diversified, Research services
Funding over time
US$598k across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Keith KleemanCEO
- Highest education
- English Literature · Xavier University
Patents
Patent filings44
Focus: Patents concentrated in chemistry & materials
CPC C12N9/13, C12P19/04, C12P19/26Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 1,226 (previous snapshot 814)
- Recorded funding
- None recorded
- Founded
- 1995 · about 31 years old
- Stage
- Unfunded
- Focus
- Instruments, Diversified
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 254 (previous snapshot 214)
- Recorded funding
- None recorded
- Founded
- 1978 · about 48 years old
- Stage
- Unfunded
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Founders · 2
Tom CaskeyCo-Founder
Art BeaudetCo-Founder
Team & hiring signals
LinkedIn headcount672501-1,000
LinkedIn followers57,234
Earlier recorded team2542022, a different source
Open roles5of 11 tracked · last posted Jun 2026
Technology
- React
- PHP
- MySQL
- Cloudflare
- Salesforce
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product
- Team size
- 168 (previous snapshot 128)
- Recorded funding
- None recorded
- Founded
- 2005 · about 21 years old
- Stage
- Unfunded
- Focus
- Antibodies, Proteomics, Research reagents and kits
Team & hiring signals
LinkedIn headcount2201,001-5,000
LinkedIn followers4,682
Technology
- AWS
- Java
- Cloudflare
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 77 (previous snapshot 66)
- Recorded funding
- None recorded
- Founded
- 2010 · about 16 years old
- Stage
- Unfunded
- Focus
- Genomics services, Full service, Research services, Genomics
Founders · 1
Qin XiangSr. Director/Co Founder
Team & hiring signals
LinkedIn headcount5851-200
LinkedIn followers4,730
Earlier recorded team772023, a different source
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 62
- Recorded funding
- None recorded
- Founded
- 2000 · about 26 years old
- Stage
- Funding Raised
- Focus
- Cro, Diversified, Bioanalytical services, Imaging
Founders · 1
John HippFounder & CSO
Team & hiring signals
LinkedIn headcount6851-200
LinkedIn followers2,416
Earlier recorded team622022, a different source
Open roles1of 4 tracked · last posted Nov 2025
Technology
- PHP
- MySQL
- Cloudflare
- Salesforce
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Genomics · 34
34 life sciences companies in Houston work in genomics. Shown: the best-documented.
ImmunotherapyDeveloper of T cell therapies for the treatment of cancer and chronic infectious diseases
Revenue modelPhysical commerce
Leadership · 1
Tom FarrellCEO
GenomicsProvider of genomic services for forensic labs
Revenue modelSubscription
Founder · 1
David MittelmanCo-Founder & CEO
Women healthDeveloper of a non-invasive pre-natal diagnostic test
Revenue modelSubscription
Founder · 1
Philip ReillyCo-Founder
GenomicsProvider of clinical intelligence platform for precision oncology and immunotherapy
Revenue modelSubscription
Founders · 3
Nick TackesCo-Founder & CTO
James WelshCo-Founder & CMO
Ryan SmithCo-Founder
OncologyDeveloper of gene therapies for rare cancers and autoimmune diseases
Revenue modelFee-for-service
Founder · 1
Lynn ZechiedrichFounder & CEO
Clinical laboratoriesState-of-the-art medical laboratory offering lab testing services for men's and women's wellness panels, allergy and infectious disease testing
Revenue modelFee-for-service
Founders
Details not available
GenomicsProvider of genetic testing and molecular diagnostics services
Revenue modelFee-for-service
Founders · 2
Tom CaskeyCo-Founder
Art BeaudetCo-Founder
Diversified diagnosticsGenetic testing and laboratory services for personalized health and ancestry solutions
Revenue modelSubscription
Founder · 1
Doron M BeharFounder
GenomicsProvider of molecular diagnostic solutions and technologies
Revenue modelSubscription
Leadership · 1
Michael StewartCEO
Biopharma outsourcingCompany offering sequencing and PCR based services for assay validation and other clinical trial applications
Revenue modelFee-for-service
Founder · 1
Qin XiangSr. Director/Co Founder
Life sciences platforms and toolsAudubon Bioscience is a medicine researcher company.
Revenue modelE-commerce - product / Physical commerce
Founders
Details not available
GenomicsProvider of products and services for genomics and proteomics research
Revenue modelPhysical commerce
Founders
Details not available
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 108
- Recorded funding
- US$137.53m · Series C · Sep 2014
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$137.53m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom FarrellCEO
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Investors · 8
- Redmile GroupFund
- Solasta VenturesFund
- VenBioFund
- RemeditexFund
Team & hiring signals
LinkedIn headcount1811-50
LinkedIn followers9,740
Earlier recorded team1082022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 22 (previous snapshot 41)
- Recorded funding
- US$48.70m · Series B · Feb 2024
- Founded
- 2018 · about 8 years old
- Stage
- Series B
- Focus
- Applied genomics, Other applications, Legal and forensic genomics
Funding over time
US$48.70m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David MittelmanCo-Founder & CEO
- Highest education
- Doctorates in molecular biophysics · Baylor College Of Medicine
Investors · 1
- GigafundFund
Team & hiring signals
LinkedIn headcount9051-200
LinkedIn followers10,482
Earlier recorded team222021, a different source
Open roles0of 1 tracked · last posted Jan 2025
Patents
Patent filings8
Focus: Secure storage and privacy-preserving processing of genomic data
CPC G06N3/123, G16B40/10Technology
- AWS
- Cloudflare
- Zendesk
- Shopify
- CloudFront
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15
- Recorded funding
- US$4.24m · Seed · Dec 2021
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- In vitro diagnostic tests, Prenatal, Applied genomics, Clinical genomics
Funding over time
US$4.24m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Philip ReillyCo-Founder
- Highest education
- Doctor of medicine in medicine · Yale University
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 6 (previous snapshot 12)
- Recorded funding
- US$3.69m · Series A · Aug 2014
- Founded
- 2013 · about 13 years old
- Stage
- Series A
- Focus
- Genome informatics, Integrative bioinformatics platforms, Research & development, Clinical trials
Funding over time
US$3.69m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Nick TackesCo-Founder & CTO
James WelshCo-Founder & CMO
Ryan SmithCo-Founder
- Highest education
- Bachelor's in computer science · Uc Irvine
Investors · 2
- SquarespaceFund
Team & hiring signals
LinkedIn headcount311-50
LinkedIn followers648
Earlier recorded team62022, a different source
Patents
Patent filings2
Focus: Personalized medicine data analysis and recommendation platform
CPC G06F19/3443, G06F19/3456Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 3
- Recorded funding
- US$1.62m · Seed · Aug 2023
- Founded
- 2013 · about 13 years old
- Stage
- Seed
- Focus
- Enabling technologies, Technology platforms, Gene delivery, Nanoenabled products
Funding over time
US$1.62m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Lynn ZechiedrichFounder & CEO
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- US$17k · Seed · Aug 2015
- Founded
- 2008 · about 18 years old
- Stage
- Seed
- Focus
- In vitro diagnostic tests, Viral, Diversified, Drugs
Team & hiring signals
LinkedIn headcount22-10
LinkedIn followers137
Technology
- Cloudflare
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 254 (previous snapshot 214)
- Recorded funding
- None recorded
- Founded
- 1978 · about 48 years old
- Stage
- Unfunded
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Founders · 2
Tom CaskeyCo-Founder
Art BeaudetCo-Founder
Team & hiring signals
LinkedIn headcount672501-1,000
LinkedIn followers57,234
Earlier recorded team2542022, a different source
Open roles5of 11 tracked · last posted Jun 2026
Technology
- React
- PHP
- MySQL
- Cloudflare
- Salesforce
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 196 (previous snapshot 139)
- Recorded funding
- None recorded
- Founded
- 2000 · about 26 years old
- Stage
- Funding Raised
- Focus
- Applied genomics, Multiple application areas
Founders · 1
Doron M BeharFounder
Team & hiring signals
LinkedIn headcount100201-500
LinkedIn followers5,844
Earlier recorded team1962022, a different source
Technology
- AWS
- Cloudflare
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 98 (previous snapshot 109)
- Recorded funding
- None recorded
- Founded
- 2016 · about 10 years old
- Stage
- Unfunded
- Focus
- Applied genomics, Consumer genomics, Proactive healthcare
Leadership · 1
Michael StewartCEO
Team & hiring signals
LinkedIn headcount58201-500
LinkedIn followers2,110
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 77 (previous snapshot 66)
- Recorded funding
- None recorded
- Founded
- 2010 · about 16 years old
- Stage
- Unfunded
- Focus
- Genomics services, Full service, Research services, Genomics
Founders · 1
Qin XiangSr. Director/Co Founder
Team & hiring signals
LinkedIn headcount5851-200
LinkedIn followers4,730
Earlier recorded team772023, a different source
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 60 (previous snapshot 67)
- Recorded funding
- None recorded
- Founded
- 2016 · about 10 years old
- Stage
- Private
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Drug discovery
Team & hiring signals
LinkedIn headcount5351-200
LinkedIn followers3,932
Open roles2of 2 tracked · last posted Mar 2026
- Hiring: Project Manager · Sofia, Sofia City
- Hiring: Turkiye Regional Director · Istanbul, Istanbul
Recent company signals
- Partnership Partnership with Panome Bio
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 18 (previous snapshot 26)
- Recorded funding
- None recorded
- Founded
- 2004 · about 22 years old
- Stage
- Funding Raised
- Focus
- Enabling technologies, Genomics, Kits and reagents, Next generation sequencing (ngs)
Team & hiring signals
LinkedIn headcount2011-50
LinkedIn followers2,150
Technology
- Vue.js
- Node.js
- Nginx
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Immunotherapy · 26
26 life sciences companies in Houston work in immunotherapy. Shown: the best-documented.
ImmunotherapyDeveloper of T cell therapies for the treatment of cancer and chronic infectious diseases
Revenue modelPhysical commerce
Leadership · 1
Tom FarrellCEO
Life sciences platforms and toolsDeveloper of T-cell therapies to treat infectious diseases
Revenue modelFee-for-service
Founder · 1
David HallalCo-Founder
ImmunotherapyDeveloper of immunotherapeutic cancer treatments targeting HLA‑G antigen
Revenue modelPhysical commerce
Founders · 2
Simon Wain-HobsonCo-Founder & CSO
Pierre DemoyenCo-Founder & Co-CEO
ImmunotherapyDeveloper of therapeutic solutions for treating tumors
Revenue modelFee-for-service
Founder · 1
Michael CurranFounder
ImmunotherapyOncolytic virus platform for treating malignant glioma.
Revenue modelSubscription
Leadership · 1
Frank TufaroCEO
ImmunotherapyBiotech targeting cellular metabolism for novel anti-cancer and anti-fibrosis therapies
Revenue modelSubscription
Leadership · 1
Dean WelschCEO
ImmunotherapyDeveloper of immunotherapies to treat cancer
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
Bob CoatesCEO
ImmunotherapyDeveloper of therapeutics for cell therapy and exosome therapy
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Howard BermanCo-Founder & CEO
OncologyDeveloper of immunotherapeutics for treating cancer
Revenue modelE-commerce - product / Physical commerce
Founders · 2
Sunil SharmaCo-Founder
Jon NorthrupCo-Founder & CEO
ImmunotherapyDeveloper of antibody inhibitors for camcer therapy
Revenue modelPhysical commerce
Leadership · 3
Gail McIntyreCEO
Ray TabibiazarCEO
Ray TabibiazarCEO
OncologyDeveloper of cancer therapies for targeting cancer-associated fibroblasts
Revenue modelFee-for-service
Founders · 3
Rosa HwangCo-Founder
Ronald DePinhoFounder
Emmanuelle SchulerFounder & CEO
ImmunotherapyDeveloper of medicines for cancer, autoimmune, and infectious diseases
Revenue modelE-commerce - product / Physical commerce
Founders · 3
Richard JonesCo-Founder
Robert Z OrlowskiFounder
Ronald A DePinhoCo-Founder
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 108
- Recorded funding
- US$137.53m · Series C · Sep 2014
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$137.53m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom FarrellCEO
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Investors · 8
- Redmile GroupFund
- Solasta VenturesFund
- VenBioFund
- RemeditexFund
Team & hiring signals
LinkedIn headcount1811-50
LinkedIn followers9,740
Earlier recorded team1082022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 97 (previous snapshot 135)
- Recorded funding
- US$151.25m · Series B · May 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Drugs, Viral, Diversified, Research services
Funding over time
US$151.25m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David HallalCo-Founder
- Highest education
- Bachelor's · University Of New Hampshire
Investors · 9
- EcoR1Fund
- ElevateBioFund
- F2 VenturesFund
- GileadFund
- InvusFund
- Redmile GroupFund
- SVB SecuritiesFund
Team & hiring signals
LinkedIn headcount1351-200
LinkedIn followers9,265
Earlier recorded team972022, a different source
Patents
Patent filings8
Focus: Ex vivo expansion and manufacturing of multivirus-specific T‑cell therapies for transplant immunotherapy
CPC C12M23/24, A61P31/20, A61K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 25
- Recorded funding
- US$44.49m · Series A · Sep 2024
- Founded
- 2010 · about 16 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Applied genomics, Clinical genomics
Funding over time
US$44.49m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Simon Wain-HobsonCo-Founder & CSO
- Highest education
- Doctorates in biochemistry · University Of Oxford
Pierre DemoyenCo-Founder & Co-CEO
- Highest education
- Institut Pasteur
Investors · 1
- BpifranceFund
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers2,866
Patents
Patent filings4
Focus: Engineered CAR‑T cell immunotherapy targeting HLA‑G antigen
CPC C07K14/7051Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14 (previous snapshot 13)
- Recorded funding
- US$44.43m · Series C · Mar 2024
- Founded
- 2019 · about 7 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Founders · 1
Michael CurranFounder
- Highest education
- Biology · University of Virginia
Team & hiring signals
LinkedIn headcount1611-50
LinkedIn followers1,518
Recent company signals
- Partnership Partnership with BostonGene
- Award SITC 2025 Award Recipients
Patents
Patent filings18
Focus: Targeted hypoxia‑activated prodrugs and STING agonist combos for cancer immunotherapy
CPC A61K31/396, A61K31/675, A61K31/7084Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 11)
- Recorded funding
- US$42.96m · Series C · Sep 2018
- Founded
- 2005 · about 21 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$42.96m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Frank TufaroCEO
- Highest education
- Bachelor's in biology · Mcgill University
Investors · 3
- Mercury FundFund
- MorningsideFund
Team & hiring signals
LinkedIn headcount411-50
LinkedIn followers2,066
Patents
Patent filings81
Focus: Oncolytic adenovirus gene therapies targeting pediatric brain tumors and immune activation
CPC A61K35/761, C12N7/00, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 9
- Recorded funding
- US$11.04m · Series B · Jan 2026
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$11.04m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Dean WelschCEO
- Highest education
- BS, ACS Approved, Chemistry · Hope College
Investors · 4
- InterVestFund
- Mirae Asset VentureFund
- NHN InvestmentFund
Team & hiring signals
LinkedIn headcount62-10
LinkedIn followers435
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 9 (previous snapshot 6)
- Recorded funding
- US$12.98m · Series A · Nov 2024
- Founded
- 2004 · about 22 years old
- Stage
- Series A
- Focus
- Drugs, Diversified, Viral
Funding over time
US$12.98m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Bob CoatesCEO
- Highest education
- Bachelor's in economics · University Of Virginia
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers837
Recent company signals
- Milestone first NSCLC patient in MEM-288 + docetaxel Phase 1 combination cohort at Moffitt Cancer Center first NSCLC patient dosed
Patents
Patent filings72
Focus: Oncolytic viral platforms and immune‑modulating vaccine adjuvants for cancer and infectious disease
CPC A61K35/761, A61P35/00, A61K35/28Technology
- PHP
- MySQL
- WordPress
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 6 (previous snapshot 10)
- Recorded funding
- US$20.44m · Series A · May 2022
- Founded
- 2020 · about 6 years old
- Stage
- Public
- Focus
- Drugs, Neurodegenerative, Diversified, Immuno oncology
Funding over time
US$20.44m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Howard BermanCo-Founder & CEO
- Highest education
- Bachelor's's degree, Biology/Biological Sciences, General · University of Michigan
Team & hiring signals
LinkedIn headcount182-10
LinkedIn followers5,805
Earlier recorded team62022, a different source
Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 6
- Recorded funding
- US$8.12m · Series A · Jan 2023
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Funding over time
US$8.12m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Sunil SharmaCo-Founder
Jon NorthrupCo-Founder & CEO
Investors · 1
Team & hiring signals
LinkedIn headcount7
LinkedIn followers719
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 5 (previous snapshot 40)
- Recorded funding
- US$24.42m · Series B · Feb 2014
- Founded
- 2008 · about 18 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$24.42m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 3
Gail McIntyreCEO
Ray TabibiazarCEO
- Highest education
- Doctor Of Medicine - Md · Harvard University
Ray TabibiazarCEO
- Highest education
- Doctor Of Medicine - Md · Harvard University
Patents
Patent filings39
Focus: AXL pathway inhibition via decoy receptors and peptides for anti‑metastatic cancer therapy
CPC C12N9/12, A61K38/177, A61K38/45Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 5
- Recorded funding
- US$15.50m · Series A · Jun 2021
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Founders · 3
Rosa HwangCo-Founder
Ronald DePinhoFounder
Emmanuelle SchulerFounder & CEO
Investors · 1
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers323
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 4 (previous snapshot 2)
- Recorded funding
- US$14.50m · Series A · Mar 2021
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Founders · 3
Richard JonesCo-Founder
Robert Z OrlowskiFounder
Ronald A DePinhoCo-Founder
Investors · 1
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore more lists: nearby cities and other sectors in Houston
123 more company lists you can search, plus the Radar directory pages for each place.
Life sciences in nearby cities
- Oakland33 life sciences companiesExplore on Radar
- San Jose110 life sciences companiesExplore on Radar
- Palo Alto165 life sciences companiesExplore on Radar
- Mountain View112 life sciences companiesExplore on Radar
- Santa Clara70 life sciences companiesExplore on Radar
- Sunnyvale123 life sciences companiesExplore on Radar
- San Mateo49 life sciences companiesExplore on Radar
- Redwood City107 life sciences companiesExplore on Radar
- Berkeley109 life sciences companiesExplore on Radar
- Santa Monica35 life sciences companiesExplore on Radar
- San Diego847 life sciences companiesExplore on Radar
- Los Angeles286 life sciences companiesExplore on Radar
Life sciences in other US cities
- New York City665 life sciences companiesExplore on Radar
- Chicago205 life sciences companiesExplore on Radar
- Austin221 life sciences companiesExplore on Radar
- Boston537 life sciences companiesExplore on Radar
- Miami106 life sciences companiesExplore on Radar
- Seattle247 life sciences companiesExplore on Radar
- Denver82 life sciences companiesExplore on Radar
- Atlanta133 life sciences companiesExplore on Radar
- Houston240 life sciences companiesExplore on Radar
- Dallas104 life sciences companiesExplore on Radar
- Philadelphia207 life sciences companiesExplore on Radar
- Washington435 life sciences companiesExplore on Radar
Other sectors in Houston
- Energy Companies in Houston, United States 978
- Business Services Companies in Houston, United States 941
- Enterprise Applications Companies in Houston, United States 533
- Real Estate and Construction Companies in Houston, United States 500
- Investment Industry Companies in Houston, United States 405
- Consumer Companies in Houston, United States 381
- Healthcare Companies in Houston, United States 328
- Financial Services Companies in Houston, United States 279
- Energy Tech Companies in Houston, United States 278
- Oil & Gas Upstream Companies in Houston, United States 267
- High Tech Companies in Houston, United States 246
- HealthTech Companies in Houston, United States 231
- Retail Companies in Houston, United States 222
- Industrial Goods and Manufacturing Companies in Houston, United States 221
- FinTech Companies in Houston, United States 199
- Oil & Gas Tech Companies in Houston, United States 193
- Oilfield Services Companies in Houston, United States 190
- Environment Companies in Houston, United States 172
- IT Services Companies in Houston, United States 172
- Marketing Services Companies in Houston, United States 170
- Consumer Goods Companies in Houston, United States 166
- Transportation and Logistics Companies in Houston, United States 156
- Food and Agriculture Companies in Houston, United States 150
- Oil & Gas Midstream Companies in Houston, United States 149
- Oil & Gas Equipment Companies in Houston, United States 135
- Sustainability Tech Companies in Houston, United States 135
- Manufacturing Services Companies in Houston, United States 130
- Real Estate and Construction Tech Companies in Houston, United States 124
- Chemicals and Materials Companies in Houston, United States 119
- Enterprise Infrastructure Companies in Houston, United States 118
- Healthcare IT Companies in Houston, United States 118
- Education Companies in Houston, United States 116
- Media & Entertainment Companies in Houston, United States 114
- HR Services Companies in Houston, United States 110
- Private Equity Funds Companies in Houston, United States 108
- Environment Tech Companies in Houston, United States 106
- Auto Companies in Houston, United States 95
- Legal Services Companies in Houston, United States 95
- HRTech Companies in Houston, United States 93
- Waste & Water Management Companies in Houston, United States 90
- Venture Capital Funds Companies in Houston, United States 81
- Oil & Gas Downstream Companies in Houston, United States 80
- Food and Agriculture Tech Companies in Houston, United States 76
- Auto Retail & Aftersales Companies in Houston, United States 74
- Oncology Companies in Houston, United States 74
- Transportation and Logistics Tech Companies in Houston, United States 73
- Travel and Hospitality Companies in Houston, United States 72
- Internet of Things - Industry Applications Companies in Houston, United States 69
- Services for Healthcare Providers Companies in Houston, United States 67
- Real Estate & Infrastructure Developers Companies in Houston, United States 66
- Infrastructure Funds Companies in Houston, United States 64
- Facility Management Services Companies in Houston, United States 64
- Professional Consumer Services Companies in Houston, United States 63
- Enterprise Software Companies in Houston, United States 62
- Freight Forwarders Companies in Houston, United States 62
- Real Estate Funds Companies in Houston, United States 61
- Building Materials Companies in Houston, United States 60
- EdTech Companies in Houston, United States 60
- Management Consulting Services Companies in Houston, United States 59
- Auto Tech Companies in Houston, United States 58
- Food Service Chains Companies in Houston, United States 58
- Investment Tech Companies in Houston, United States 58
- Construction Contractors Companies in Houston, United States 55
- Investment Banks Companies in Houston, United States 53
- Logistics Tech Companies in Houston, United States 53
- Cybersecurity Companies in Houston, United States 52
- MarketingTech Companies in Houston, United States 52
- SaaS Companies in Houston, United States 51
- Telecom Companies in Houston, United States 49
- Aerospace, Maritime and Defense Tech Companies in Houston, United States 48
- Clinic Chains Companies in Houston, United States 48
- Native AI Companies in Houston, United States 47
- Real Estate Brokers Companies in Houston, United States 47
- Semiconductors Companies in Houston, United States 46
- Nonprofits Companies in Houston, United States 46
- Artificial Intelligence Companies in Houston, United States 45
- B2C E-Commerce Companies in Houston, United States 45
- Legal Tech Companies in Houston, United States 44
- Travel and Hospitality Tech Companies in Houston, United States 44
- Insurance Distribution Companies in Houston, United States 43
- Finance & Accounting Services Companies in Houston, United States 42
- Unbundling of Craigslist Companies in Houston, United States 41
- Asset Management Companies in Houston, United States 40
- Food Tech Companies in Houston, United States 40
- Construction Tech Companies in Houston, United States 39
- Facility Management Tech Companies in Houston, United States 39
- Aerospace, Maritime and Defense Companies in Houston, United States 38
- Fashion Tech Companies in Houston, United States 38
- Clinics Companies in Houston, United States 37
- Food & Beverage Products Companies in Houston, United States 37
- Manufacturing Tech Companies in Houston, United States 37
- Chemicals and Materials Tech Companies in Houston, United States 36
- Energy Efficiency Tech Companies in Houston, United States 36
- Life Sciences Platforms and Tools Companies in Houston, United States 36
- Services for Investment Industry Companies in Houston, United States 36
- Foundations Companies in Houston, United States 35
- Genomics Companies in Houston, United States 34
- K-12 Schools Companies in Houston, United States 33
- Sports Tech Companies in Houston, United States 33
No list matches. Try a shorter word.